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Eukaryotic K+ channels from the SLO family (SLO1, SLO2 and SLO3) provide a 
link between intracellular signaling and the electrical activity of a cell. The 
opening and closing (gating) of the three different SLO homologs is controlled by 
the synergistic action of membrane voltage and specific intracellular cues: Ca2+ 
binding in SLO1, Na+ binding in SLO2 and pH increase in SLO3. It is known that 
intracellular signals activate SLO channels by acting on the large cytoplasmic 
domains (CTDs) of these proteins, which follows the transmembrane ion-
conduction pore. However, a molecular description of the mechanisms of 
intracellular gating in SLO channels is still lacking.  
In this thesis, I present biochemical, structural and functional studies 
aiming at understanding how the activity of SLO1 and SLO3 channels is 
controlled by intracellular Ca2+ binding and pH increase, respectively. First, I 
describe recombinant methods for the large-scale expression and purification of 
functional SLO channels, paving the way for a more complete biochemical and 
structural analysis of these proteins. Then, I report the crystal structures of the 
large cytoplasmic domains (CTDs) from two different SLO1 channels. Structures 
of the Ca2+-bound CTDs from human and zebrafish SLO1 channels define the 
precise molecular architecture of SLO1’s Ca2+-sensing module: CTDs from the 
four subunits of a tetrameric SLO1 channel assemble in a so-called gating ring 
structure at the intracellular face of the membrane. In conjunction with other 
studies, these results describe how Ca2+ binding affects the conformation of one 
layer of the SLO1 gating ring, which can explain the Ca2+-driven opening of 
SLO1’s ion conduction pore. Next, I present the crystal structure of the human 
SLO3 gating ring. A comparison with the SLO1 structures suggests that the 
hSLO3 structure represents the open conformation of the hSLO3 gating ring. 
Finally, I describe functional mutagenesis studies on the mouse SLO3 ortholog, 
which reveal a possible mechanism for pH sensing in the mouse SLO3 channel. 
Surprisingly, the mechanism I propose appears not to be conserved in SLO3 
channels from other species. This could be a dramatic example of how new 
functional mechanisms can easily evolve within the very versatile scaffold of a 
gating ring structure.  
Altogether, the results presented in this thesis provide a molecular 
framework to understand the mechanisms of intracellular gating in SLO 
channels. 
  





À mes parents, Josette et Charles, pour m’avoir accompagné dans toutes mes aventures, 
des deux côtés de l’Atlantique. 
  




Being a graduate student in the MacKinnon laboratory has been, at so many 
levels, a fantastic adventure. My first thanks go to my advisor Rod. Rod, your 
communicative passion for science, and the rigor and clarity of your thinking 
have inspired me tremendously. Working with you made me a better scientist. 
Thank you. 
 
One aspect of Rod’s genius is his ability to bring together an amazing group of 
scientists. I am truly grateful to all members of the MacKinnon lab for their help 
and friendship. I learned so much by working close to all of you. First and 
foremost, I am particularly indebted to my colleague and mentor Peng Yuan for 
his extraordinary support over the years. We made a great team. I also want to 
sincerely thank Liang Feng for his help and generosity. Thanks also to Yichun 
Hsiung for her continuous help, and to Jose Avalos for guiding my first steps in 
the lab. I also want to thank our collaborators Maria Garcia and Bill Schmalhofer 
for their assistance and advice.  
 
Thanks to Seth Darst, Brian Chait, Chris Miller and Jacques Neyton for their time 
and advice as members of my thesis committee. And thanks to the Dean’s Office 
for their commitment to the students.  
 
The love and support of my family and friends have had a huge influence on my 
ability to do the best possible science during my Ph.D. In particular, I am truly 
thankful to my parents for their everlasting support.  
  
	   v 
TABLE OF CONTENTS 
CHAPTER 1: INTRODUCTION 
 
     1.1 - Electrical signaling in cells and ion channels 
    1.2 - The SLO family of K+ channels: physiology 
    1.3 - SLO channels: functional mechanisms 
    1.4 - Research project 
 
CHAPTER 2: EXPRESSION OF FULL-LENGTH SLO CHANNELS IN EUKARYOTIC  
                          HETEROLOGOUS SYSTEMS  
 
     2.1 - Heterologous expression of SLO channels 
    2.2 - Functional studies of purified SLO1 channels  
    2.3 - Progress towards a SLO channel structure 
    2.4 - Discussion 
 
CHAPTER 3: CRYSTAL STRUCTURES OF THE Ca2+-BOUND SLO1 CYTOPLASMIC  
                          DOMAIN AND MECHANISM OF Ca2+ GATING 
 
     3.1 - Structure of the human SLO1 Ca2+ activation apparatus 
    3.2 - Structure of the Ca2+-bound, open SLO1 gating ring 
    3.3 - A structural model for SLO1 Ca2+-driven opening  
 
CHAPTER 4: CRYSTAL STRUCTURE OF THE HUMAN SLO3 CTD: IMPLICATIONS 
                           FOR  pH SENSING IN SLO3 CHANNELS  
 
     4.1 - Structure of the human SLO3 gating ring 
    4.2 - Mechanism of pH sensing in mouse SLO3 channels  
 
CHAPTER 5: DISCUSSION - INTRACELLULAR GATING OF SLO CHANNELS BY  
                          EUKARYOTIC GATING RINGS  
 













































	   vi 
LIST OF FIGURES 
 
 
Figure 1: The molecular components of life’s electrical system 
 
Figure 2: Membrane voltage 
 
Figure 3: SLO channels: activation and phylogeny 
 
Figure 4: Conserved architecture of SLO channels  
 
Figure 5: SLO / voltage-gated channel negative feedback interplay 
 
Figure 6: Structural homologs of SLO channels 
 
Figure 7: Closed and open pores in K+ channel structures 
 
Figure 8: MthK gating ring 
 
Figure 9: FSEC screening in HEK cells 
 
Figure 10: Expression and purification of SLO1 channels 
 
Figure 11: Pore-blocker toxins 
 
Figure 12: Labeling of IbTx-D19C 
 
Figure 13: SLO1 pull-down on IbTx resin 
 
Figure 14: 14C-IbTx binding to purified AcSLO1T in DM micelles 
 
Figure 15: Electrophysiological recordings of reconstituted AcSLO1T from 
Sf9 expression 
 
Figure 16: SLO1 proteolysis and RCK1-RCK2 linker deletion 
 
Figure 17: Effect of Ca2+ and Mg2+ on purified SLO1 gel filtration profile 
 
Figure 18: Comparing detergents for SLO1 solubilization 
 
Figure 19: Monomer structure of the human SLO1 CTD 
 
Figure 20: The Ca2+ bowl 
 
Figure 21: Gating ring assembly of hSLO1 
 















































	   vii 
Figure 23: zSLO1 Ca2+-bound, open gating ring structure 
 
Figure 24: Conformational changes between the closed and open SLO1 
gating rings structures 
 
Figure 25: Conformational changes between subunits from the closed and 
open SLO1 structures 
 
Figure 26: A Ca2+-gating model for the SLO1 channel 
 
Figure 27: pH activation of human and mouse SLO3 channels 
 
Figure 28: Structure of the human SLO3 gating ring 
 
Figure 29: Comparison between the structure of individual subunits from 
the hSLO3 and SLO1 gating rings 
 
Figure 30: All-Cα atoms superposition of the hSLO3 and open/closed 
SLO1 gating rings 
 
Figure 31: RCK1 N-lobes superposition of the hSLO3 and open/closed 
SLO1 gating rings 
 
Figure 32: D912N and H417A mutants in mSLO3 channel 
 
Figure 33: A model for pH gating in mSLO3 channels 
 
Figure 34: Co-expression of SLO3 channels with LRRC52 
 
Figure 35: Comparison of the SLO1 and MthK gating ring structures 
 




































	   viii 
LIST OF TABLES 
 
 
Table 1:  Summary of crystallography data for the monomeric Ca2+-bound 
hSLO1 CTD structure presented in Chapter 3 
 
Table 2:  Summary of crystallography data for the Ca2+-bound zSLO1 
gating ring structure presented in Chapter 3 
 
Table 3:  Summary of crystallography data for the hSLO3 gating ring 






























	   2 
 
Living cells are sophisticated information-processing machines. In order 
to perform the essential functions of survival of the organism or transmission of 
genetic material, a cell must perceive and process information about both its 
environment and its own physiological state. Within the cell, a wide range of 
signals acting in concert allow this information to be integrated and transmitted, 
to ultimately coordinate the action of the various cellular components that will 
elicit an appropriate response. One of the most ubiquitous forms of cellular 
signaling is electrical in nature: by controlling the distribution and movement of 
ions (that is, electric charges), a cell can encode signals in the form of a voltage 
across the lipid membrane surrounding it. This voltage can in turn be sensed by 
specialized proteins in the cell to regulate their activity.  
At a very general level, the work presented here aims at understanding 
some specific aspects of how electrical signaling is used and controlled in cells. I 
studied a family of eukaryotic proteins called the SLO potassium channels, 
which regulate the electrical activity of a cell in response to an intracellular 
stimulus. In a sense, SLO channels translate information about intracellular 
activity into electrical signaling. The main question I am interested to address is 
how this translation occurs at the molecular level, in other words by which 
mechanisms intracellular activity modulates these proteins in order to control 
their function. 
To appreciate the biological role of SLO channels, I will start by 
introducing the basic principles of electrical signaling in cells. I will then present 
in detail the SLO family of K+ channels, insisting on their physiological roles and 
functional properties. I will finish this introduction by describing my research 
project and the motivation for my work. 
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1.1 - ELECTRICAL SIGNALING IN CELLS AND ION CHANNELS 
 
 
1.1.1) “Animal electricity” 
Electricity is an essential part of life’s toolbox. For example, the electrical 
signals that we can visualize in an electrocardiogram control our heartbeats. 
Which form, then, does electricity take in a living cell?  
Any electrical phenomenon is intrinsically linked to the movement of 
electric charges. In biology, these charges are the inorganic ions (mostly: Na+, K+, 
Ca2+ and Cl-) present in the aqueous environment that makes up the interior and 
the surroundings of living cells (1, 2). As first envisioned by Julius Bernstein in 
the very beginning of the 20th century (3), it is the controlled movement of these 
ions in and out of cells that generates electrical signals (1, 2). In addition to 
inorganic ions, life’s electrical system is based on three essential components: the 
hydrophobic cell membrane, and two classes of proteins called ion pumps (also 
called ion transporters) and ion channels (Figure 1). The cell membrane is a thin 
oil-like lipid bilayer that separates the cell’s interior from its environment. The 
hydrophobic character of the membrane forbids the free crossing of most 
components of cells and their external milieu, in particular ions. The movement 
of ions across the membrane is carried out by proteins embedded in and 
spanning through the lipid bilayer: ion pumps and ion channels (1, 4). Ion 
pumps use energy to force the transport of ions in one specific direction, and 
thus generate concentration gradients across the membrane. Ion channels, which 
are the focus of my work, do not use energy and are therefore passive pores in 
the membrane that can only let ions diffuse along their (electro)chemical gradient 
(5).  
  

















Figure 1: The molecular components of life’s electrical system. Two kinds of proteins 
embedded in the cell membrane control the movement of ions. Pumps use energy to 
create ionic concentration gradients, while channels are passive pores letting ions flow 
down their electrochemical gradients.  
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1.1.2) Ion channels are at the core of the cell’s electrical network 
 Electrical signals in cells are encoded in the form of a voltage (difference 
of electric potential) across the membrane. To act as a signal, the transmembrane 
voltage must satisfy two essential criteria: it should be 1) precisely controllable 
and 2) able to influence downstream effectors. The dynamic control of the cell’s 
voltage arises from two central properties of ion channels: selectivity and gating.  
Most channels are selective: they only allow a specific type of ion to cross 
through their pore, excluding others. When an ion channel opens, the membrane 
voltage at equilibrium is set at the reversal potential, i.e. the point at which 
diffusion and electric driving forces commanding ion flow exactly balance each 
other. For a selective ion channel, Nernst’s law of electrodiffusion shows that this 
reversal potential is determined solely by the ratio of ion concentration outside 
vs. inside the cell (Figure 2a). The action of dedicated pumps ensures that these 
concentration ratios are different for Na+, K+, Ca2+ or Cl- ions. Selective channels 
for each of these ions exist, such that the opening of a Na-, K-, Ca- or Cl-selective 
channel sets the membrane voltage at different values (Figure 2b) (1, 2). Non-
selective cation channels, which do not discriminate between cations but prevent 
the conduction of anions and reverse at 0 mV, form another important class of 
channels. At rest, the cell is polarized: the voltage is more negative inside 
(typically -70 mV in animal cells) due to the opening of K+ and Cl- channels (2, 6-
8). During activation or signal transmission, the membrane voltage becomes less 
negative (depolarization) owing to the action of Na+, Ca2+ or non-selective cation 
channels (1, 2, 9). When multiple channels are opened at once, each specific 
channel type drives the membrane voltage towards its own reversal potential, 
and the overall potential depends on the number and strength of each individual 
conductance. Hence, by controlling the opening of particular kinds of selective 
ion channels, cells can modulate the value of the transmembrane voltage and 
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Figure 2: The different reversal potentials of selective ion channels allow information 
to be encoded in the membrane voltage. 2a) The ratio of ionic concentration across the 
membrane sets the reversal potential (Erev) of a selective ion channel according to the 
Nernst equation (R: gas constant; T: temperature; z: ionic charge; F: Faraday constant). 
2b) This ratio varies for the different ionic species in a cell (Na+, Ca2+, K+, Cl-), so that the 
reversal potential of the corresponding selective ion channels are different (values are 
given for a typical mammalian skeletal muscle cell). 2c) Opening of specific selective 
channels controls the membrane voltage, allowing information to be encoded (showing 
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encode information (Figure 2c). This is another essential functional feature of ion 
channels, known as gating: channels respond to specific signals that govern their 
opening and closing. Multiple modes of gating exist, ranging from binding of a 
ligand to the action of light (1).  
In essence, ion channel gating mediates the tuning of the membrane 
voltage to encode information. Downstream, the transmission of these signals is 
ensured by specialized membrane proteins that can sense the voltage and 
modulate their activity in response to it. These proteins are said to be voltage-
dependent, and in fact the most ubiquitous voltage-dependent proteins are ion 
channels themselves (1, 10). The interplay between membrane voltage and 
opening of voltage-gated channels is the basis for the conduction of action 
potentials, first described in the seminal work of Hodgkin and Huxley (11). 
However, voltage sensing is not restricted to channels, as demonstrated by the 
recent discovery of Ci-VSP, a phosphatase enzyme whose activity is governed by 
membrane voltage (12). 
 
1.1.3) Electrical signaling is ubiquitous 
 Historically, the study of electrical signaling focused on tissues like nerves 
and muscles where electrical phenomena manifest themselves perhaps the most 
obviously. Neurons or muscle fibers belong to the family of excitable cells, in 
which activity is controlled by the propagation of action potentials (1). The 
outcome of action potential propagation is the opening of voltage-gated Ca2+ 
channels, and the subsequent entry of Ca2+ is the trigger for the main functional 
response of excitable cells: release of synaptic vesicles in neurons, or 
actin/myosin sliding in muscular fibers, for example. 
 Nonetheless, the basic components of the cellular electrical system are 
present in virtually every cell type and every organism. In particular, voltage-
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gated proteins are ubiquitous (1, 6, 13). Since the core function of these proteins 
is to sense variations in the membrane voltage, their ubiquity mirrors the 
universality of electrical signaling in nature. For example, as I will discuss later, 
one of the proteins I studied extensively is specific to sperm cells. Moreover, 
electrical signaling is not restricted to animal cells and is used by plants as well 
as unicellular organisms, often to allow a rapid response to environmental 
changes (1). Examples include the folding of Mimosa leaves upon touch (14, 15) 
or the obstacle avoidance response in Paramecium (16). Recently, the discovery of 
rhythmic variations in the membrane voltage of the bacterium Escherichia coli 
suggests that electrical signaling might be a very ancient form of functional 
regulation in cells (17).  
 
Altogether, electrical signaling – that is, encoding of information in the 
form of a voltage across the cell membrane – is central to many aspects of cellular 
physiology. Since the opening and closing of specific ion channels controls the 
membrane voltage, understanding how ion channels gate is a key step towards 
understanding the cellular responses governed by electrical signaling, from 
information processing in the brain to the ability of a sperm cell to fertilize an 
egg. Understanding how ion channels gate is precisely my interest. My main 
focus is the study of a family of eukaryotic K+ channels called SLO, which 
regulate many cellular functions, which I will describe in the next section.  
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1.2 – THE SLO FAMILY OF K+ CHANNELS: PHYSIOLOGY 
 
 
1.2.1) Overview of the SLO family of K+ channels 
 SLO channels are K+-selective pores expressed in animal cells, and are 
gated by both membrane voltage and intracellular signaling. Since K+ ions are 
more concentrated inside the cell than outside, opening of a SLO channel 
hyperpolarizes the membrane and moderates the overall electrical activity of a 
cell. Three types of SLO channels exist (SLO1, SLO2 and SLO3), which vary by 
the kind of intracellular cue responsible for their activation (Figure 3a). SLO1, 
SLO2 and SLO3 are activated by the binding of intracellular Ca2+, intracellular 
Na+ or an increase in intracellular pH, respectively (18). Figure 3b shows the 
basis of SLO1 activation by membrane voltage and intracellular Ca2+:  voltage 
and Ca2+ act in synergy to open the SLO1 pore. The same basic principle applies 
to the activation of SLO2 and SLO3 by voltage and Na+ or alkalization, 
respectively. 
The activation of SLO1, SLO2 and SLO3 by different intracellular signals 
underlies the fundamentally different functional roles these proteins play in cells. 
These differences are reflected in the modest conservation of amino acid 
sequence between the three homologs (Figure 3a). Especially, SLO2 is quite 
divergent from SLO1 and SLO3, which are much closely related in sequence and 
number of transmembrane helices (see below). Nonetheless, the three members 
of the SLO family share common core properties. 
 First of all, all SLO channels share the same basic architecture (Figure 4). 
As most K+ channels, SLO channels are homo-tetramers in the membrane (19, 
20). The transmembrane pore of one protomer contains six transmembrane 
helices (S1-S6), similar to canonical voltage-gated K+ channels: S1 to S4 make up 

































Figure 3: SLO channels: activation and phylogeny. 3a) SLO1, SLO2 and SLO3 are 
activated by different intracellular signals. The phylogenic relationship shown at the 
bottom right can be inferred by comparing the sequences of the three homologs. 3b) 
Activation of SLO1 by voltage and Ca2+: the channel’s open probability is shown as 
function of intracellular Ca2+ concentration and membrane voltage (adapted from 224).   
3a 
3b 
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the unit responsible for voltage sensing (at least in SLO1 and SLO3), whereas S5 
and S6 form the pore responsible for ion flow (21). SLO1 and SLO3 (but not 
SLO2) possess an additional transmembrane N-terminal helix, S0 (22). Following 
S6, all three channel types have a large cytosolic domain that controls 
intracellular activation (18, 23). This CyTosolic Domain, or CTD, is made of a 
tandem of so-called RCK domains: RCK1 and RCK2 (24).  
 Another similarity arises from the main functional role of SLO channels in 
cells: SLO channels act as negative feedback switches to regulate the intracellular 
concentration of the same ions that activates them. This is best described for the 
Ca2+-activated SLO1 (25, 26). Functional and biochemical studies have 
established that SLO1 co-localizes with voltage-dependent Ca2+ channels in most 
cell types (25-29). When the cytosolic Ca2+ concentration rises, SLO1 opens and 
the resulting hyperpolarization drives the closing of voltage-gated Ca2+ channels 
in the plasma membrane, thereby shutting off one of the main source of Ca2+ 
entry into the cytoplasm (Figure 5). Overall, the Ca2+-driven opening of SLO1 
results in a decrease of intracellular Ca2+ itself. The precise mode of action of 
SLO2 and SLO3 is less well characterized, but it is very likely that the same 
negative feedback interplay exists between SLO2 and voltage-gated Na+ channels 
or SLO3 and voltage-gated proton channels, both pairs being known to be 
expressed in the same cell types (30-32).  
 
1.2.2) SLO1 (BK, Maxi-K) channels 
 SLO1 channels (also known as BK or Maxi-K) were the first of the SLO 
family to be discovered and characterized. Following the finding that internal 
Ca2+ could activate potassium flux in tissues (33), the development of patch-
clamp and reconstitution techniques lead to the identification of a specific kind of 
Ca2+-activated K+ channel with an unusually large unitary conductance (~100-300 











Figure 4: Conserved architecture of SLO channels. The topology of a SLO subunit is 
shown on the left (the S0 transmembrane helix is not present in SLO2). The voltage 
sensor, pore, RCK1 and RCK2 domains are shown in orange, green, blue and red 
respectively. In the membrane, four identical subunits assemble in a tetrameric channel 
(right, same color-code as previously). The voltage sensors from the front and back 




Figure 5: SLO / voltage-gated channel negative 
feedback interplay. 3a) SLO1 opening inhibits 
voltage-gated Ca2+ channels by hyperpolarizing 
the membrane, thereby shutting off one of the 
main sources of Ca2+ entry in the cytoplasm. 3b) 
The same interplay is likely to exist between SLO2 
and voltage-gated Na+ channels, or SLO3 and 
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pS in symmetrical 150 mM K+, to be compared to ~25 pS for the archetypical 
Shaker delay-rectifier K+ channel) (34, 35). This property gave the protein its 
name: BK (for Big-K) or Maxi-K (36, 37). A mutation at the slowpoke locus was 
discovered in Drosophila that abolishes BK currents in the fly muscles (38), paving 
the way for the molecular cloning of the corresponding gene, slo (39-41). After 
the discovery of the related SLO2 and SLO3 channels, BK was renamed SLO1, 
which is the nomenclature I will be using here (18). 
 SLO1 channels are expressed throughout the animal kingdom (Metazoa). 
SLO1 has a remarkably wide range of expression in human tissues, including 
neurons, smooth and skeletal muscles, endocrine cells, kidney, pancreas or even 
cartilage. Looking specifically in the brain, immunocytochemistry studies in mice 
detected SLO1 expression in almost all brain regions (42). The ubiquity of SLO1 
in different cell types likely reflects the universal physiological importance of 
Ca2+ signaling (43-45). In excitable cells, where its function is best characterized, 
SLO1 is involved in controlling neuronal activity, neurotransmitter release, 
smooth and skeletal muscle tone or hair cell tuning, all of which involve Ca2+ 
entry through voltage-gated Ca2+ channels (18, 27, 46-52). The role of SLO1 in 
non-excitable cells is less well established, but recent studies have proposed that 
SLO1 currents, by hyperpolarizing the cell, regulate the driving force for Ca2+ 
influx through the plasma membrane or from intracellular stores (53, 54). The 
wide physiological importance of SLO1 is reflected in the range of phenotypes of 
SLO1 knock-out (KO) mice: KO animals are viable but exhibit ataxia, impaired 
vasodilatation and vascular hypertension, incontinence, high-frequency hearing 
loss and erectile dysfunction (55-59). 
The diversity of cellular functions involving SLO1 is also mirrored by a 
large array of physiological processes that regulate the channel’s properties. The 
functional characteristics of SLO1 currents are modulated extensively by 
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alternative splicing, complex phosphorylation, lipidation and binding of 
cofactors (18, 60-64). Another level of complexity arises from the interaction of 
SLO1 with other proteins in the cell. In particular in tetrapods (including 
mammals), SLO1 is associated with a class of proteins known as β-subunits 
which significantly alter its function (26). The first β-subunit, β1, was originally 
identified in smooth muscles where it co-purifies with SLO1 (65, 66). The 
elucidation of β1’s primary sequence revealed that it contains two 
transmembrane helices linked by a large, glycosylated extracellular loop (67), 
and allowed the cloning of three other kinds of β-subunits based on sequence 
similarity (β2, β3, β4) (68-73). β-subunits affect SLO1 function in different ways: 
β1, β2 and β4 modulate both voltage-gating, apparent Ca2+ sensitivity and 
activation/deactivation kinetics (73-76), and β2 and β3 confer fast inactivation 
through a ball-and-chain mechanism (68, 69, 77). The phenotypes of KO mice for 
β1 and β4 emphasize the functional importance of β-subunits, showing impaired 
vasoregulation, bladder contraction and airway dilation for β1 (78-81), and 
increased hippocampal activity for β4 (82). β-subunits are not the only proteins 
known to interact with SLO1 (18, 60). In particular LRRC26, a leucine-rich repeat-
containing (LRRC) protein, has been recently described to dramatically activate 
SLO1 currents in prostate cancer cells (83). The discovery that a related LRRC 
protein also activates SLO3 raises the interesting possibility that members of this 
protein family are general interacting partners of SLO channels (83).  
Taken together, the vast diversity of modifications and interactions that 
regulate SLO1 explains how the functional characteristics of SLO1 currents are 
fine-tuned in different cell types (18). A fascinating example of how subtle 
variations of SLO1 properties are important for cellular function is found in the 
cochlea, where the expression of different SLO1 splice variants and the gradual 
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expression of β1-subunits define the precise electrical resonant frequency at 
which individual hair cells are set to respond (50).  
 
1.2.3) SLO2 (Slick, Slack) channels 
 Expression of Na+-activated K+ channels (KNa) is well established in the 
animal nervous system, from arthropods to mammals (30, 84). Their presence has 
also been suggested in mammalian muscles, but might be species-specific (see for 
example (85)). In neurons, KNa function is intimately linked to the excitatory 
entry of Na+ during synaptic transmission or action potential propagation, and 
KNa currents have been shown to regulate the shape of the action potential, the 
firing rate of neurons or the kinetics of excitatory synaptic response (30, 31, 84, 
86-88).  
 The vast majority of KNa channels are believed to be encoded by Slo2 (30). 
SLO2.2 (also known as Slack) was first cloned based on sequence similarity with 
SLO1 (89), and was later shown to be activated by intracellular Na+ (90). The 
SLO2.1 (Slick) paralog was subsequently discovered based on sequence 
homology (91). Both SLO2.1 and SLO2.2 are Na+-activated, but vary in their 
functional details: SLO2.1 opens rapidly, is also activated by intracellular Cl- and 
inhibited by ATP binding, whereas SLO2.2 displays slow “on” kinetics, is weakly 
Cl--dependent and insensitive to ATP (30, 91). Immunocytochemistry and in situ 
hybridization experiments in rat showed that SLO2.1 and 2.2 are widely 
expressed in the brain, in particular in the olfactory bulb, visual and 
somatosensory cortex, midbrain, hippocampus and brainstem (89, 92, 93). The 
distribution of SLO2 matches the known abundance of KNa currents in the 
nervous system, reinforcing the idea that most native KNa are encoded by SLO2 
(30). However, the lack of specific pharmacological agents for SLO2 has hindered 
the precise functional characterization of SLO2 channels in tissues. 
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1.2.4) SLO3 (KSper) channels 
 The third member of the SLO family is present only in mammals, and is 
specific to sperm cells (94). SLO3 is activated by membrane voltage and 
intracellular alkalinization (94, 95). The pH-dependence of SLO3 reflects the fact 
that intracellular pH (pHi) is a master regulator of activity in mammalian sperm. 
pHi increase activates two essential properties of sperm cells: their motility (i.e., 
the ability to reach the egg) and their capacity of fertilization (i.e., the ability to 
break through the egg’s membrane and deliver DNA) (32). From the testis to the 
ovaries, sperm cells experience a gradual increase in extracellular pH, which 
translates into an increase in pHi owing to the action of proton pumps and 
proton channels in the mammalian sperm membrane (32, 96).  
 Voltage-sensitive ion channels in sperm cells are involved in both 
regulating and sensing variations of pHi. In human sperm cells (but not in mice), 
the voltage-gated proton channel Hv1 is a key regulator of pHi (32, 97, 98). 
Furthermore, one of the direct effect of pHi increase is the opening of pH-
dependent voltage-activated Ca2+ channels (CatSper, described in mouse and 
human sperm), which controls many aspects sperm activation (98-100). Hence, 
pHi and electrical signals are intimately linked in the physiology of sperm cells.  
 To date, SLO3 function has been almost exclusively studied in mice, 
although its expression in human sperm has been shown at the RNA level (94). 
Electrical recordings of mouse sperm cells using the patch-clamp technique 
revealed the existence of an alkaline-activated K+ current (KSper) (101), which 
was later shown to be carried by SLO3 channels (102-104). Genetic knock-out 
studies in mice highlighted the physiological importance of SLO3 in male 
fertility. SLO3 KO mice are completely infertile under natural conditions, and 
KO sperm cells show morphological defects, impaired motility and 
compromised ability to undergo the acrosome reaction (103, 104). Importantly, 
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fertilization with KO sperm cells could be achieved in vitro, but with much lower 
rate of success than with wild-type cells (103, 104). Another interesting aspect of 
the KO phenotype relates to the response of sperm cells to osmolarity changes. 
Upon ejaculation, mammalian sperm cells must adapt to a decrease in 
extracellular osmolarity, and one study showed that the motility and 
morphological defects of SLO3 KO cells are exacerbated at low osmotic 
conditions, raising the possibility that SLO3, on top of its role in controlling the 
electrical balance of sperm cells, might also act as an osmoregulator (104).  
 Finally, as in the case of SLO1, SLO3 function is likely to be regulated by 
transmembrane interaction partners in cells. The SLO1 β-subunit β4 is expressed 
in mouse sperm, and might act as a chaperone for SLO3, increasing SLO3 surface 
expression without significantly modulating its functional properties (105). 
Recently, LRRC52, a newly discovered protein from the leucine-rich repeat 
containing family, has been reported to co-assemble with SLO3 in mouse sperm 
and to potentiate the pH sensitivity of SLO3 currents when expressed in 
heterologous systems (106). 
 
1.2.5) SLO channels as therapeutic targets 
Owing to their diverse physiological roles, SLO channels have long been 
recognized as important drug targets (107-110). In particular, the ubiquitous 
importance of SLO1 in smooth muscle physiology makes it an attractive 
candidate for the treatment of a wide range of disorders such as asthma, 
hypertension, urinary incontinence or erectile dysfunction (110). This is further 
emphasized by the discovery that human genetic variations in the SLO1 β1-
subunit cause asthma (111) or can directly affect blood pressure regulation (112). 
Interestingly, some drugs currently on the market have been shown to act 
through molecular pathways dependent on SLO1: examples include β-adrenergic 
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agonists used for the treatment of asthma (113, 114), or phosphodiesterase 
inhibitors (e.g. Viagra) used against erectile dysfunction (115). In addition, SLO1 
has also recently emerged as a regulator of different kinds of human cancers, and 
in vitro experiments have shown that SLO1 blockers can inhibit the proliferation 
of specific types of cancer cells (116, 117). 
 
 
 Overall, the physiological roles of SLO channels in cells highlight the 
central importance of intracellular activation for their function: these channels 
are expressed in cells where changes in intracellular Ca2+, Na+ or pH are essential 
for activity. Moreover, the conserved architecture of SLO channels suggests 
similarities in their mechanism of action. My thesis work aims at understanding 
how SLO channels’ function is regulated at the molecular level, and in particular 
probing how the effects of the Ca2+, Na+ or pHi translate into channel opening. In 
the next section, I will describe in more details our molecular and mechanistic 
understanding of SLO channels’ function. 
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1.3 – SLO CHANNELS: FUNCTIONAL MECHANISMS 
 
 
1.3.1) Domain architecture 
 What is already known about the mechanisms of SLO channel activation 
at the molecular level? In the absence of detailed atomic structures of SLO 
channels, it is difficult to understand precisely the molecular events leading to 
channel opening. However, insights about SLO channels’ structure and 
mechanism can be drawn from the known structure of evolutionarily related K+ 
channels, which I will detail in this section (for excellent reviews, see (118) and 
(21)). 
As we have seen, each subunit of a tetrameric SLO channel can be divided 
into three functional domains: the voltage sensor and the pore embedded in the 
lipid bilayer, and the CyToplasmic Domain (CTD) (Figure 6). The pore is the 
basic unit of ion conduction and selectivity, and contains the channel’s activation 
gate. Channel opening and closing is ultimately controlled by conformational 
changes happening in the pore. The function of the gating modules, voltage 
sensors and CTD, is to sense gating signals and transfer the corresponding 
energy to the pore domain to trigger opening in an allosteric manner. The pore, 
voltage sensor and CTD domains are related to different classes of channels for 
which structural data are available, and which shed light on the structure and 
function of SLO channels. 
 
1.3.2) Pore domain and activation gate 
 The structure of the truncated bacterial K+ channel KcsA, which is 
essentially an isolated pore domain, defines the basic principles of ion 
conduction and selectivity in all K+ channels (119, 120). KcsA shows how protein 

































Figure 6: Structural homologs of SLO channels. For each SLO channel domain (voltage 
sensor, pore and CTD), a structural homolog is shown (respectively: voltage sensor from 
the paddle chimera Kv, PDB ID 2R9R, KcsA pore, PDB ID 1K4C, and MthK RCK 
domains, PDB ID 1LNQ). For KcsA, K+ ions are shown in purple spheres, and the front 
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residues provide a pathway allowing ions to cross the membrane: a central 
aqueous cavity stabilizes hydrated ions in the low dielectric environment of the 
lipid bilayer, and the selectivity filter close to the extracellular side acts as a 
gatekeeper responsible for K+ selectivity. The precise geometry of the filter 
provides a polar environment mimicking the specific coordination of K+ ions by 
water molecules, explaining how K+ can move through at a rate close to their 
diffusion limit in water and why other ions such as Na+, which prefer a different 
coordination, are excluded (120, 121).  
Since the selectivity filter and the inner helices (S6 in SLO) of the pore are 
the only regions lining the ion pathway, they must contain the channel’s 
activation gate that switches ion flow on or off. The crystal structure of the 
ligand-bound MthK, a bacterial Ca2+-gated K+ channel, provides a striking 
illustration of how the movement of the inner helices contributes to channel 
gating (122, 123). In the Ca2+-bound, open conformation of the MthK structure, 
the inner helices are bent outwards providing a physical access to the inner 
cavity from the intracellular side (Figure 7) (123). In contrast, in KcsA the same 
helices form a narrow (~4 Å) hydrophobic bundle at the intracellular entry, 
forbidding the movement of K+. Subsequent structural characterization of other 
K+- or related channels reinforced the concept that the movement of inner helices 
is central to channel activation (124-131). In MthK, the open inner helices bend at 
a Gly residue (“Gly hinge”) that is conserved throughout the K+ channel family 
and is a major determinant of channel activation (123, 132).  
How do these principles apply to SLO channels? All the relevant studies 
have so far focused on SLO1. Functional experiments revealed that, in SLO1, 
rearrangement of the inner helices occurs during the closed-to-open transition 
(133, 134). Importantly, two consecutive Gly are present in SLO1 at the position 
corresponding to the “Gly hinge” in MthK. Mutation of either Gly to Ala impairs  





















Figure 7: Closed and open pores in K+ channel structures. The pore regions of the 
closed KcsA (PDB ID 1K4C) and the open MthK (PDB ID 1LNQ) are shown. In MthK, 
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SLO1 opening, and in the double Ala mutant the voltage required to open the 
channel in 100 µM Ca2+ is shifted by ~ 130 mV to higher values (132). Thus, inner 
helix flexibility is an important aspect of SLO1 gating. Whether the same applies 
to SLO2 or SLO3 remains to be tested. Additionally, the precise conformational 
changes occurring in SLO1’s inner helix during activation are still to be 
characterized (21, 133-136). 
 
1.3.3) Voltage sensors 
 In canonical voltage-gated channels, functional and structural studies 
have revealed that voltage-sensing stems from the movement, in response to 
voltage changes, of positively charged amino acids (“gating charges”) located in 
the S4 transmembrane helix (1, 137-142). Gating charge movement manifests 
itself in a measurable “gating current” prior to channel opening (143). Functional 
experiments coupling mutagenesis and gating current measurement in the 
archetypical Shaker voltage-gated K+ channel identified the implicated residues in 
S4 (four Arg and one Lys), and established that each Shaker tetramer contains 12-
14 gating charges, or ~3.5 per individual voltage sensor.  The crystal structures of 
the bacterial KvAP and the eukaryotic Kv1.2 and Kv1.2/Kv2.1 “paddle chimera” 
channels define the molecular architecture of the voltage sensor in classical 
voltage-dependent K+ (Kv) channels, and show that voltage sensors (S1 to S4) are 
essentially independent domains embedded in the lipid bilayer (124, 125, 141). 
The linker between S4 and the pore’s outer helix, S5, provides the allosteric 
connection that translates voltage sensor movement into pore opening (138). 
 The voltage dependence of SLO1 and SLO3 likely originates from the 
same principles. Sequence analysis reveals that most of Shaker’s gating charge 
residues are conserved in SLO1 or SLO3 (94, 144). However, there is a 
discrepancy between this apparent conservation of number of charged residues 
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in S4 and the actual number of gating charges: gating currents have been 
measured in SLO1 (145), but quantitative measurements showed that SLO1 
possess only 2-4 gating charges per tetramer (144, 145), compared to Shaker’s 12-
14 (146, 147). Mutagenesis studies in SLO1 further showed that, in S4, only the 
last Arg (R213) carries a gating charge (144). Hence, the actual structure of the 
voltage sensors of SLO1 (and probably SLO3) is surely pretty divergent from that 
of canonical Kv channels. Another important difference is the presence in SLO1 
and SLO3 of the additional transmembrane helix S0, which has been proposed to 
directly interact with the core of the voltage sensor domains based on 
mutagenesis and cross-linking experiments (148, 149).  
Lastly, the voltage dependence of SLO2 remains largely unexplained since 
its S4 segment does not show any obvious conservation of positively charged 
residues, even though SLO2 currents are voltage-sensitive (90, 150).  
 
1.3.4) CTD: tandem RCK domains and functional implications 
 The basic architecture of the large intracellular CTD is expected to be 
conserved among the different SLO channels, based on sequence conservation 
(151). An elegant proof that the CTD is the basic unit responsible for intracellular 
activation, and that CTDs from different SLO channels are indeed similar in 
structure, came from experiments using chimeras between SLO1 and SLO3. By 
swapping CTDs between SLO1 and SLO3, Lingle and colleagues showed that the 
CTD alone is responsible for the specific response to Ca2+ vs. pHi: a chimeric 
channel with a SLO1 transmembrane domain (S0 to S6) and a SLO3 CTD 
becomes alkalization-activated but Ca2+-insensitive, and vice versa (23).  
 It was first recognized by sequence analysis that the CTD is evolutionary 
related to a class of protein domains ubiquitous in prokaryotic K+ channels and 
K+ pumps: the RCK domains (for Regulating the Conductance of K+) (24, 151-
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154). The first snapshot of the RCK domain fold came from the crystal structure 
of the RCK domain from the E. coli K+ channel (24), which also suggested that the 
functional RCK unit is formed by a dimer of RCK domains interacting through a 
large protein interface. A salt bridge can be seen in the structure, and is 
conserved in the sequence corresponding to RCK1 in SLO channels as 
demonstrated by mutant-cycle mutagenesis studies in SLO1 (24). This proved the 
existence of at least one RCK domain in the CTD of SLO channels. In-depth 
sequence analysis showed that another RCK domain (RCK2) could be found in 
the SLO CTD, so that the CTD actually contains a tandem of RCK domains (151, 
151). 
Subsequently, the structure of the prokaryotic Ca2+-activated K+ channel 
MthK offered the first picture of a full channel whose gating apparatus is formed 
by RCK domains (122). The sequence of MthK encodes only one RCK domain, 
but an alternative start site at the RCK N-terminus initiates the translation of a 
second identical RCK domain that assembles with the first, pore-attached RCK in 
the full channel, showing that dimerization is a trademark of RCK function (122) 
(Figure 8a). Moreover, in the MthK tetramer, four RCK dimers are seen to 
assemble in a “gating ring” at the intracellular surface of the membrane (122) 
(Figure 8a). The structure suggested a simple hypothesis for RCK-mediated 
gating in MthK: in response to Ca2+ binding, conformational changes at the RCK 
level cause a dilation of the gating ring, which in turn pulls the pore’s inner 
helices to open the channel (122). This mechanism was later confirmed by 
crystallographic studies on an isolated MthK gating ring (without the pore 
domain) in which the Ca2+ binding site was disabled by mutation, most likely 
representing the “closed” conformation of the gating ring (155). Comparison of 
this structure with the original Ca2+-bound, open gating ring shows that upon  
  




























Figure 8: MthK gating ring. 8a) Structure of the MthK tetrameric gating ring (PDB ID 
1LNQ). The topology of one subunit in shown in inset: the MthK CTD is made by the 
repeat of the same RCK domain. In all panels, RCK1 and RCK2 are color-coded blue and 
red, respectively. 8b) Ca2+ causes the MthK gating ring to expand, leading to channel 
opening. The gating rings are seen from the top, and the red spheres mark the very N-
terminal CTD residues, linked to the channel pore. PDB ID: 2FY8 (closed), 1LNQ (open).  
gating ring 
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Ca2+ binding the ring’s diameter expands from 66 to 74Å, driving channel 
opening (122, 123, 155, 156) (Figure 8b).  
 The presence of a RCK tandem in SLO channels strongly suggests 
similarities in function with MthK. In addition, the “gating ring expansion” 
model predicts that the amino-acid linkers between the pore’s inner helices and 
the RCK N-termini serve essentially as passive tethers transducing the 
mechanical force of gating ring dilation into channel opening. Functional 
experiments in SLO1 where the linker length was systematically modified 
support this model, showing that increase or decrease in the length, respectively, 
impairs or potentiates Ca2+-driven activation, and that this effect varies linearly 
with length, the linker acting essentially as a spring (151, 157). Altogether, the 
structure and mechanism of MthK provides a basic framework for 
understanding the activation of SLO channels by intracellular signals. 
 
1.3.5) Ca2+ activation in SLO1 
 What more is known about the functional mechanisms of SLO channel 
activation by Ca2+, Na+ or pHi? In particular, where in the CTD is the ligand 
binding site or sensor located? Here again, only SLO1 has been studied in detail. 
The first insight into the location of the Ca2+ binding site(s) in the SLO1 CTD took 
advantage of the different Ca2+ sensitivities of mouse and drosophila channels. 
Swapping RCK2 between the two channels established that this domain is 
responsible for the difference (158). More detailed mutagenesis analysis 
narrowed down the RCK2 sequence critical for Ca2+ activation: a stretch rich in 
Asp residues, absolutely conserved across species, named the “Ca2+ bowl” by the 
authors (889QFLDQDDDDDPD900, numbering corresponding to the human 
protein) (159). A systematic alanine scan of the whole Ca2+ bowl and flanking 
regions revealed that mutating two of the Asp (D895 and D897) had the most 
severe effect (160). Furthermore, radioactive assays in which 45Ca2+ binding can 
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be detected on a RCK2 fragment containing the Ca2+ bowl (161, 162) showed that, 
in the double mutant D895A-D897A, 45Ca2+ signal is reduced by 80%, further 
suggesting that the corresponding side chains might directly coordinate Ca2+ 
(160, 160). Another study involved chimeric SLO1/SLO3 channels (163). 
Replacing the RCK2 domain of SLO1 by the corresponding SLO3 sequence 
creates channels that are completely Ca2+-insensitive. Now, in this background, 
introducing back a SLO1 region of 34 amino-acids encompassing the Ca2+ bowl 
restores most of the Ca2+ sensitivity (163). Thus, the calcium bowl appears to be 
the main Ca2+ binding site responsible for SLO1 activation.  
 However, the Ca2+ bowl is likely not the only Ca2+ binding site in SLO1. 
Indeed, deleterious mutations in the Ca2+ bowl sequence abolish most, but not 
all, of SLO1’s Ca2+ sensitivity (159). In particular, SLO1 channels in which the 
Ca2+ bowl region (893QDDDDDPD900) is completely removed are still functional 
and Ca2+-activated: raising [Ca2+] from 3 nM to 10 µM Ca2+ causes a -80 mV shift 
in the midpoint of voltage activation (compared to -170 mV in wt channels) (164). 
The precise location of the other Ca2+ binding site(s) is still unknown. Three 
residues located in RCK1 have been implicated (D367, M513 and E535) (164-166). 
Mutating either of these residues to Ala almost abolishes the high-affinity (<10 
µM) response to Ca2+ in the background of a Ca2+-bowl-disabled SLO1 channel 
(164-166). However, whether these amino acids directly coordinate Ca2+ or act 
through an indirect effect is unresolved. In particular, direct biochemical 
evidence for Ca2+ binding in RCK1 is missing. 
 Importantly, none of the proposed high-affinity Ca2+ binding sites appear 
to match the binding sites seen in the MthK structure (122, 151). Hence, even 
though MthK and SLO1 likely share similarities in how conformational changes 
at the CTD level drive channel opening, the details of how the energy of Ca2+ 
binding is transduced into channel activation surely differ between the two 
channels.  
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1.4 – RESEARCH PROJECT 
SLO channels: studying the structure to understand function 
 
 
 Overall, SLO channels are an important class of K+ channels involved in a 
myriad of physiological processes ranging from muscle contraction to sperm 
motility. Understanding the gating of these channels is key to understanding the 
specific cellular functions controlled by their activity. The evolutionary link 
between the SLO family and other channels of known molecular structure 
provides a basic framework for understanding the gating mechanisms of SLO1, 
SLO2 and SLO3. However, as we have seen, the unique features of SLO channels 
(be it in terms of voltage- or intracellular activation) cannot be explained by 
simply drawing parallels between SLO channels and their distant relatives (21, 
118, 151, 167). To really understand how SLO channels operate at the molecular 
level, a direct knowledge of the atomic structure of these proteins is needed. 
Such knowledge would pave the way for functional studies specifically designed 
to probe particular aspects of SLO channels’ operation.  
 The goal of my Ph.D. work is to study the atomic structure of SLO 
channels, and to use this information to discover new aspects of how these 
molecular machines perform their function in cells. To this end, I used two 
experimental techniques: X-ray crystallography, which is a way to directly 
investigate the atomic arrangements of any molecule (in particular proteins); and 
electrophysiology, which allows the direct study of the function of ion channels 
by measuring the electrical currents they mediate.  
In addition to the fascinating challenge of understanding the chemical and 
physical foundations of cellular functions (especially in the context of human 
physiology), this work is also motivated by its potential contribution to the 
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treatment of diseases. As we have seen, SLO channels (and in particular SLO1) 
are attractive drug targets. Structural information can be instrumental in the 
design and development of therapeutic molecules (168), as shown by the 
example of HIV protease inhibitors used for the treatment of AIDS (169, 170). 
Furthermore, the biochemical characterization and large-scale production effort 
that preludes any crystallographic analysis can also lead to the development of 
new tools for pharmacological studies. 
 
 
 The specific questions I decided to study relate to the distinctive, key 
property of SLO channels: their activation by intracellular signals. Can we 
understand how binding of an ion, or a change in pH, modulate these proteins to 
promote channel opening? Since SLO1, SLO2 and SLO3 are closely related, do 
they share the same principles of activation? For example, do Ca2+, Na+ and pHi 
act on the same site(s) in the three homologs, or did evolution make use of 
different opportunities within the same basic protein scaffold? 
 As we will see, structural studies of eukaryotic proteins as complex as 
SLO channels constitute an important technical challenge, and I was very 
fortunate to work on this project alongside two very talented scientists: first and 
foremost Peng Yuan, a post-doc, whose excellent expertise and mentorship was 
central to the work I will present; and Yichun Hsiung, a research assistant, whose 
skillfulness was essential for dealing with the large amount of cell culture that 
this project required. All the data I will describe in this dissertation are 
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 In my thesis, I will describe our effort to characterize structurally SLO 
channels, as well as to use this structural knowledge to probe fundamental 
aspects of how SLO channels function, in particular how channel activation is 
mediated by ligand binding or pH change at the intracellular level. In the next 
chapter, I will present our endeavors to crystallize entire SLO channels, and my 
work on developing methods to express large quantities of full-length SLO1 
channels in eukaryotic heterologous systems, and to purify these proteins while 
making sure they retain full functionality. Using a specific toxin-binding assay as 
a probe, I will show how expression and purification of functional SLO1 is highly 
dependent on the choice of expression system, but can be achieved in insect or 
mammalian cell lines.  
In the subsequent chapters, I will describe our results on determining the 
atomic structures of isolated CTDs from SLO1 and SLO3. In Chapter 3, we will 
look at two structures of the human and zebrafish SLO1 CTDs, solved by Peng in 
the presence of Ca2+. We will see how, together with studies from other 
laboratories, these structures illustrate how the binding of Ca2+ in the SLO1 CTD 
changes the conformation of the protein to open the channel pore. In Chapter 4, I 
will describe the structure I solved of the human SLO3 CTD and present 
electrophysiological results that explain the molecular mechanisms of pH 
sensing in mammalian SLO3 channels. In the final discussion, I will compare 
these different structures together and examine how they define new unique 
properties of SLO channels regulation by intracellular signals, and discuss the 
evolutionary relationship of RCK-mediated ion channel gating. 
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 As we have seen, direct knowledge of the atomic structure of SLO 
channels is required to understand the precise molecular events controlling 
gating in these proteins. X-ray crystallography is the primary experimental 
method to obtain structural information of proteins at the atomic scale. An X-ray 
crystallography experiment involves two major steps: first, one must find 
suitable conditions to obtain three-dimensional crystals of the protein of interest; 
then, the atomic details of these crystals are probed under an X-ray beam, and 
the resulting data are processed into an atomic structure of the proteins forming 
the crystal. The major bottleneck in X-ray crystallography is to obtain protein 
crystals. Crystallization of proteins follows the same principles of crystallization 
as for any molecule or mineral. To crystallize, a molecule in solution needs to be 
brought above its solubility limit: the solution then becomes supersaturated and 
metastable, leading to precipitation or, if the right conditions are met, 
crystallization. The most common way to reach the solubility limit is to increase 
the concentration of the molecule.  
 Thus, crystallizing proteins typically requires high concentrations of 
starting material. In practice, this means that large quantities of proteins need to 
be obtained. To this end, two options are available. The first one is to make use of 
a natural tissue where the protein is enriched. The other option is to force the 
expression of the protein in a heterologous system. Heterologous expression is 
often the method of choice in present-day crystallography because it allows one 
to work with proteins for which no practical natural source is available (as is the 
case for SLO channels) and it allows tailoring the protein of interest to facilitate 
its subsequent purification and crystallization.  
 Crystallography of membrane proteins presents unique challenges. First, 
heterologous over-expression of membrane proteins is particularly difficult, due 
to the complexity of membrane protein folding and the limited area of the cell 
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membrane (171, 172). Second, current biochemical techniques require that 
membrane proteins be extracted from the native lipid bilayer in a water-soluble 
form, typically by solubilizing the hydrophobic transmembrane core in a 
detergent micelle (173). Eukaryotic membrane proteins such as SLO channels are 
even more difficult to work with, and the first eukaryotic membrane protein 
structure obtained using heterologous expression was solved only recently, in 
2005 (1).  
 The first goal of my Ph.D. work was to develop methods for the large-
scale production and purification of SLO channels, the necessary first step of any 
crystallographic undertaking. In this chapter, I describe my efforts to express 
functional SLO1 channels in three different systems commonly used for 
eukaryotic protein expression (172): Pichia pastoris yeast, Sf9 insect cells and 
human HEK cell line. As a first approach to probe the functionality of the 
purified proteins, I developed techniques to screen whether purified SLO1 
channels obtained from these different expression systems are able to bind a 
specific toxin molecule that recognizes only properly folded SLO1 tetramers. I 
will show that SLO1 channels expressed from HEK or Sf9 cells, but not from 
Pichia yeast, are competent to bind the toxin and are indeed fully functional. 
  
	   35 
2.1 – HETEROLOGOUS EXPRESSION OF SLO CHANNELS 
 
 
2.1.1) Eukaryotic expression systems 
 I tested three eukaryotic systems for the heterologous over-expression of 
SLO channels: the yeast Pichia pastoris, Sf9 insect cells and HEK human cell line 
(172). Each system has its own specificities. Yeast can be grown in large 
quantities using fairly inexpensive media, and Pichia cells in particular can reach 
very high density compatible with fermentor culture (up to >100 g dry weight of 
cells per liter of culture) (174). Yeast cells can carry out most, but not all, post-
translational modifications common to animal cells. Pichia is capable of 
producing membrane proteins at high level. However, the lipid composition of 
the Pichia membrane is quite different from that of a typical animal cell (for 
example, yeast lack cholesterol). The first eukaryotic membrane protein structure 
obtained using heterologous expression (the mammalian Kv1.2 potassium 
channel) made use of the Pichia system (125). On the other hand, Sf9 or HEK cells 
are bona fide animal cells that can be used for protein over-expression, but require 
expensive cell culture media (172). HEK cells offer the most native environment 
for the expression of mammalian membrane proteins, but these epithelial cells 
are best grown attached on a surface, which limits large-scale production efforts 
in practice. Sf9 insect cells can be conveniently grown in shaker flasks, and are 
often the system of choice for eukaryotic protein expression (172).   
 
2.1.2) Screening of SLO candidates using FSEC 
 I proceeded to screen the SLO family for candidates amenable for large-
scale production and purification. Typically, a good membrane protein candidate 
for crystallization must fulfill three criteria: 1) have a sufficiently high yield of 
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expression in the system of choice, 2) be stable, i.e. not prone to rapid 
degradation upon purification and 3) be homogeneous, i.e. give rise to a 
monodisperse species upon extraction from the lipid membrane by detergent 
solubilization (175). FSEC (Fluorescent Size Exclusion Chromatography) is a 
powerful method to screen for such candidates (175). In an FSEC experiment, the 
protein of interest is fused to a GFP (Green Fluorescent Protein) molecule and the 
biochemical behavior of the protein-GFP construct is followed by fluorometry 
within the whole cell lysate, so that only small amounts of material are needed 
and no purification is required. After cell lysis and detergent extraction, the 
protein-GFP fusion is loaded on a gel filtration column that separates molecules 
according to their size (size exclusion chromatography). A protein that is stable 
and homogeneous will typically elute as a single, sharp peak on FSEC (175). 
 In an initial screen, I tested 9 different SLO1, SLO2 or SLO3 channels from 
different species for expression in Pichia, Sf9 or HEK, the rationale being that 
differences in protein sequence between species can have a big impact on the 
ability of a protein to crystallize. These candidates represented all SLO channels 
that had been cloned at the time (y. 2006), except for mammalian SLO1 channels, 
which share extremely high amino-acid sequence identity (for example, 
sequences from mouse and human SLO1 are 96% identical): for this clade, the 
human SLO1 was chosen as a representative candidate. This initial screen 
identified three promising candidates: SLO1 channels from human and the sea 
slug Aplysia californica, and the rat SLO2.2. Representative FSEC profiles for these 
three channels, expressed in HEK cells, are shown in Figure 9a. Expression in Sf9 
or Pichia gave identical results (data not shown). A representative candidate that 
did not pass the FSEC test (Caenorhabditis elegans SLO1) is shown in Figure 9b. A 
close inspection of the data in Figure 9a reveals interesting differences in the 
biochemical behavior of the three promising candidates: Aplysia SLO1 (AcSLO1) 
























Figure 9: FSEC screening in HEK cells. SLO 
channels were expressed in HEK cells as C-
terminal GFP fusions, and the crude DDM-
solubilized cell lysate was loaded on a Superose 6 
gel filtration column, monitoring GFP fluorescence. 
All traces are at the same scale. 9a) Best candidates. 
The hSLO1 profile shows signs of non-specific 
aggregation: a “shoulder” left of the main peak (#). 
9b) Example of a bad candidate.  
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and rat SLO2.2 elute as single, monodisperse peaks, whereas the human SLO1 
(hSLO1) gel filtration profile shows a high-molecular weight “shoulder” on the 
left of the main peak, sign that the solubilized hSLO1 channel has a tendency to 
aggregate. In terms of expression level, the yield for rat SLO2.2 is half compared 
to that of AcSLO1.  
 Based on these initial results, I decided to focus on the two SLO1 
candidates (AcSLO1 and hSLO1). AcSLO1 appeared to be the most promising 
target, and the hSLO1 FSEC profile was encouraging enough to pursue, 
considering that the structure of a human protein would have the biggest impact 
on our understanding of human physiology and on new therapeutic possibilities.  
 
2.1.3) Large-scale production and purification of AcSLO1 and hSLO1 channels 
 Large-scale production and purification of Aplysia AcSLO1 and human 
hSLO1 were carried out using the Pichia and Sf9 systems. The purification was 
done in three steps: 1) Pichia and Sf9 cells expressing AcSLO1 or hSLO1 were 
lysed either mechanically (Pichia) or by sonication (Sf9) and membrane proteins 
were extracted using n-dodecyl-β-D-maltoside (DDM) or n-decyl-β-D-maltoside 
(DM) detergents; 2) the solubilized SLO1 channels were isolated from the crude 
cell lysate by affinity chromatography; and 3) the channels were further purified 
in a final gel filtration step. To facilitate affinity purification, I engineered an 
affinity tag within the protein constructs. Initial attempts using a C-terminal 
poly-His tag gave samples of low purity because of the relatively low expression 
yield of hSLO1 or AcSLO1 in Pichia and Sf9: in this case the non-specific binding 
of background contaminants to the affinity resin was too high. High purity was 
achieved using a C-terminal 1D4 tag (TETSQVAPA), for which very specific 
monoclonal antibodies are available. Some of the constructs I used also contained 
a C-terminal GFP between the SLO1 sequence and the affinity tag, so that the 
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channel construct can be easily followed by fluorometry at different steps during 
purification. In order to remove the C-terminal 1D4 tag or GFP-1D4 tag prior to 
crystallization, a protease cleavage site was added to the construct following the 
SLO1 sequence. Two different cleavage sites were compared: a thrombin site and 
a site recognized by the PreScission protease. Only PreScission showed specific 
cleavage restricted to the engineered site, whereas thrombin treatment led to 
additional non-specific proteolysis (data not shown). Schematics of the final 
optimized expression constructs, obtained by fusing a PreScission site-1D4 tag or 
a PreScission site-GFP-1D4 tag to the SLO1 C-terminus, are shown in Figure 10a. 
 By growing large cultures of Pichia or Sf9 cells, AcSLO1 and hSLO1 
channels could be purified in milligram quantities (final protein yield per liter of 
culture for either AcSLO1 or hSLO1: ~0.3 mg in Pichia; ~0.2 mg in Sf9). Gel 
filtration profiles from the final purification step are shown in Figure 10b and 10c 
(DDM was used as detergent). Three important characteristics can be seen in 
these profiles. First, the gel filtration behavior of channels obtained from Pichia or 
Sf9 cultures is essentially identical (compare Figures 10b and 10c). Second, the 
elution volume of the main peak is consistent with purified channels being in a 
tetrameric form. This was confirmed by chemical crosslinking experiments (see 
Figure 10d showing the example of hSLO1 purified from Pichia, but the same 
was observed with proteins purified from Sf9). Third, both AcSLO1 and hSLO1 
exhibit signs of non-specific aggregation, which manifests itself as a “shoulder” 
on the left of the main tetramer peak. When the tetramer peak is isolated, 
concentrated and re-loaded on the gel filtration column, the channel further 
aggregates, with hSLO1 behaving worse than AcSLO1 in this respect (Figure 
10b). Over time, the isolated AcSLO1 tetramer peak will aggregate as well and 
display a visible “shoulder” on gel filtration (data not shown). 
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 Overall, this large-scale purification effort seemed promising: AcSLO1 and 
hSLO1 could be purified in quantities compatible with crystallization efforts, and 
the channels were purified in their native oligomeric state. Before starting 
intensive crystallization efforts, I decided to probe whether the purified channels 
were also still fully functional. 
  































Figure 10: Expression and purification of SLO1 channels. 10a) Constructs used for 
large-scale protein expression: C-terminal fusions containing PreScission site-1D4 tag or 
PreScission site-GFP-1D4 tag (see text). PreScission protease is used to remove the added 
C-terminal sequence during purification (red). 10b) Gel filtration profiles of AcSLO1 and 
hSLO1 purified from Pichia, solubilized in DDM (Superose 6 column). Peaks 
corresponding to SLO1 tetramers (asterisks) were isolated, concentrated and re-loaded 
on the column (“re-run”). 10c) Same as in 10b) showing AcSLO1 and hSLO1 purified 
from Sf9 expression. Peaks eluting at 17-20 mL mostly contain GFP. 10d) SDS-PAGE 
showing chemical crosslinking of the isolated hSLO1 tetramer peak from Pichia 
expression. Increasing concentrations of disuccinimidyl glutarate were used for 
crosslinking. The SDS-PAGE was stained with Coomasie. 
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2.2 – FUNCTIONAL STUDIES OF PURIFIED SLO1 CHANNELS 
   
 
2.2.1) Toxin binding as a probe of SLO1 functional state 
 The absolute test to probe whether a purified ion channel retains its full 
functional state is to reconstitute the solubilized channel into a lipid bilayer from 
which ion channel function can be directly assessed by electrophysiology (176, 
177). However, this method is time- and protein-consuming. Instead, I decided to 
first study the ability of purified AcSLO1 and hSLO1 to bind toxins recognizing 
specifically the native state of the channels. Natural peptides found in the venom 
of scorpions have been shown to act as high-affinity blockers of K+ channels 
(178). These “pore-blocker” toxins occlude ion conduction in cells by binding to 
the channel’s extracellular mouth, at the interface between the four subunits of 
the pore (Figure 11) (178, 179). Toxins can be extremely specific for a particular 
kind of K+ channel, and toxin binding is a powerful tool to assess whether a 
given channel retains its native state upon purification (180). Several toxins from 
the charybdotoxin (ChTx) family, including ChTx itself, target SLO channels 
(178). In particular iberiotoxin (IbTx), isolated from the venom of the Indian red 
scorpion Buthus tamulus by the team of Maria Garcia at Merck Research 
Laboratories, is a specific blocker of SLO1 (181). I therefore performed IbTx-
binding assays to study the biochemical properties of AcSLO1 and hSLO1 
expressed in heterologous systems. 
 
2.2.2) 125I-IbTx binding assays on DDM-solubilized hSLO1 
 Maria Garcia and her colleagues have extensively studied binding of 
ChTx and IbTx (the two toxins have nearly identical properties) to membrane-
embedded as well as solubilized hSLO1 (182, 183). Their standard protocol  
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Figure 11: Pore-blocker toxins. 
Toxins from scorpion venom 
occlude ion conduction by binding 
at the extracellular interface 


































Figure 12: Labeling of IbTx-D19C. 12a) 
Position of the introduced Cys (shown as 
spheres) in the toxin molecule. 12b) HPLC 
profile of the last purification step from E. 
coli expression (see Material and Methods). 
The main peak corresponds to pure IbTx-
D19C (asterisk). 12c) HEK cells expressing 
GFP-tagged hSLO1 (green) were incubated 
with 90 nM IbTx-D19C fluorescently 
labeled with tetramethylrhodamine (TMR, 
red). A competition assay in the presence 
of large excess of unlabeled IbTx shows 
that the binding is specific. 
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makes use of toxin derivatives radiolabeled with 125I by iodination on Tyr 
residues. In a binding assay, solubilized hSLO1 or membrane preparations 
containing hSLO1 are incubated with 125I-ChTx or 125I-IbTx, and the toxin-
receptor complex is recovered by filtration on treated glass filters, which are then 
counted for 125I γ radiation (1).  
 Electrophysiology experiments done in extracellular salt conditions close 
to physiological levels (90 mM Na+ and 2.5 mM K+) show that 125I-IbTx blocks 
hSLO1 with a KD of ~1.5 nM, almost identical to native IbTx (KD ~1 nM) (183). 
However, binding affinity can be increased by removing all external K+ and 
using an extracellular buffer of very low ionic strength. Using a buffer containing 
only 10 mM NaCl and 20 mM TRIS-HCl pH 7.4 (+ 0.1% BSA to limit non-specific 
binding), 125I-IbTx binds in vitro to membranes containing hSLO1 with a KD of ~5 
pM (183). These specific conditions (0 K+ and low ionic strength) have been used 
in all toxin binding studies published so far, because the very high affinity allows 
using minimal amounts of radiolabeled toxin.  
 Toxin binding on solubilized hSLO1 has been studied using the same 
conditions. The Garcia lab showed that picomolar 125I-ChTx binding on 
solubilized hSLO1 could be achieved using digitonin as a detergent, but not 
DDM (182). Digitonin is an unusual detergent that interacts with membrane 
cholesterol and solubilizes membrane proteins along with an annulus of 
phospholipids (184). Digitonin is very expensive, toxic and difficult to obtain in a 
pure and homogeneous form, all of which undermine its practical use for 
membrane protein crystallization (185, 186). On the other hand, mild glycosydic 
detergents such as DDM or DM are well-suited and very commonly used for 
crystallization efforts (186).  
 With the help of Maria Garcia and her colleagues, I attempted to 
reproduce their findings using DDM-solubilized hSLO1 obtained from Pichia or 
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Sf9 expression. Indeed, under the standard 0 K+ and low ionic strength 
conditions, we could not detect any picomolar 125I-IbTx binding to these samples 
(data not shown). Does this mean that, in DDM micelles, solubilized hSLO1 is 
denatured in a non-native, toxin-insensitive form? This would be a significant 
drawback for our crystallographic undertaking. However, I reasoned that 
another phenomenon could explain these results. It is known that, at least in 
detergent micelles, the selectivity filter of K+ channels changes its conformation 
depending on K+ concentration (120). At low [K+] (~2 mM), the crystal structure 
of KcsA shows that the selectivity filter adopts a “collapsed” conformation 
drastically affecting the geometry of the K+ binding sites (120). Interestingly, it is 
known that pore-blocker toxins such as ChTx or IbTx bind in the immediate 
vicinity of the filter’s K+ sites (178, 187). Hence, it is possible that, in the standard 
125I-toxin binding protocol using non-physiological K+-free conditions, the 
conformation of hSLO1 is affected in a way that prevents toxin binding (most 
probably due to a conformational change in the channel’s selectivity filter). To 
test this hypothesis, I needed to perform toxin-binding studies in the presence of 
K+.  
 
2.2.3) Development of a K+-compatible IbTx binding assay  
 In practice, 125I-IbTx cannot be used to study toxin-channel interactions in 
the presence of K+. This is because the synthesis of large quantities of radioactive 
125I-IbTx is quite inconvenient, so that its usage is limited to conditions where 
toxin binding has picomolar affinity (i.e. 0 K+, low salt conditions), thus allowing 
the use of very low quantities of material. I thus decided to develop a new IbTx 
binding assay, which would be compatible with K+-containing buffers. 
 Toxins from the ChTx family can be recombinantly expressed in bacteria, 
and introducing a Cys residue at position 19 (on the toxin’s upper surface) allows 
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for specific labeling of the toxins without compromising their binding 
capabilities (188, 189) (Figure 12a). Using protocols originally described for ChTx 
(188), I could produce and purify the Cys mutant IbTx-D19C expressed in E. coli 
(see  Materials and Methods section). An HPLC profile of the final purification 
step is shown in Figure 12b. IbTx-D19C can be labeled on the introduced cysteine 
and the labeled toxin binds hSLO1 with high affinity. An example is shown on 
Figure 12c: IbTx-D19C labeled with the red fluorophore tetramethylrhodamine 
(TMR, using a Cys-reactive maleimide conjugate) specifically binds HEK cells 
expressing hSLO1 (toxin concentration: 90 nM).  
 To study IbTx binding on solubilized hSLO1, I first covalently linked 
IbTx-D19C onto a Cys-reactive iodoacetyl agarose resin. The IbTx-coated resin 
could then be used to pull-down solubilized hSLO1, and test the influence of [K+] 
on the channel-toxin interaction. The results of such pull-down experiments are 
shown in Figure 13a. In these experiments, hSLO1-GFP was solubilized from 
HEK cells using either digitonin or DDM. The crude cell extract was then 
incubated with IbTx resin, and hSLO1 binding to the resin was revealed by SDS-
PAGE, looking at GFP fluorescence. Figures 13a and 13b shows the requirement 
of K+ for toxin binding on DDM-solubilized hSLO1; on the contrary, when 
digitonin is used, binding occurs independently of K+ concentration. 
Interestingly, for IbTx binding in DDM, K+ must be present during solubilization 
itself: adding K+ to hSLO1 solubilized in a K+-free buffer does not rescue binding 
(Figure 13b). In the case of AcSLO1, the wild-type protein does not bind IbTx due 
to a sequence variation at the toxin receptor site (190). However, I could confer 
IbTx binding to AcSLO1 by introducing, by mutagenesis, the hSLO1 sequence 
corresponding to the expected receptor site (190) (a total of 7 mutations, see 
Figure 13c). This mutant AcSLO1 (which I will from now on refer to as AcSLO1T, 





























Figure 13: SLO1 pull-down on IbTx resin. 13a) IbTx-coated agarose resin binding to 
hSLO1-GFP solubilized in either digitonin or DDM. SDS-PAGE revealed by GFP 
fluorometry are shown. Each panel shows three lanes: total solubilized hSLO1 (“total”); 
hSLO1 bound to IbTx-coated agarose resin (“IbTx”); non-specific binding to agarose 
resin not conjugated to IbTx (“mock” beads). Both hSLO1 solubilization and resin 
binding are carried out in buffer containing either 0 K+ or 30 mM K+. 13b) Densitometry 
quantification of experiments as in 13a). hSLO1 was solubilized in either digitonin or 
DDM. Specified K+ concentrations are used during both solubilization and resin binding 
(0 or 30 mM, “throughout”), or during resin binding only (30 mM, solubilization carried 
out in 0 K+). Binding is normalized to total solubilized material. 13c) Sequence alignment 
showing the mutations introduced in AcSLO1T to confer toxin sensitivity (cyan). The 
selectivity filter sequence is shown in yellow. Numbers correspond to hSLO1 sequence 
numbering. 13d) Same as 13b) showing normalized binding of AcSLO1wt and IbTx-
sensitive AcSLO1T. Channels were solubilized in DDM in the presence of 30 mM K+. 
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for toxin) binds to IbTx resin when solubilized in DDM in the presence of K+ 
(Figure 13d). 
 Overall, the IbTx-resin pull-down experiments proved that SLO1 channels 
can indeed be solubilized in DDM and still bind IbTx, provided that high enough 
[K+] is present. These results gave a qualitative analysis of IbTx binding on 
solubilized SLO1.  
 
2.2.4) Quantitative IbTx binding on purified SLO1 from Pichia and Sf9 expression 
 To truly assess the functional state of purified SLO1 channels obtained 
from Pichia or Sf9 large-scale expression, a quantitative assay was needed. In 
essence, I wanted to answer the following question: what proportion of channels 
can be purified in a toxin-binding competent, presumably native state? To this 
end, I turned to radioligand binding assays. 
 I labeled IbTx-D19C with 14C-N-ethylmaleimide, a commercially available 
Cys-reactive radioactive probe, following protocols already described for similar 
experiments with ChTx (188). 14C labeling was essentially complete: the specific 
activity I measured for the labeled 14C-IbTx using spectroscopic absorbance at 280 
nm (A280) to calculate toxin concentration was in excellent agreement with the 
expected value (measured: 31.5 ±0.3 Ci/mol, expected: 33.2 Ci/mol). 
Importantly, I could easily produce large quantities of 14C-IbTx, compatible with 
binding assays for which binding interaction is in the nM range. 
 With this tool in hand, I performed quantitative 14C-IbTx binding assays 
on purified SLO1 channels from Pichia and Sf9 expression. I used a protocol that 
was essentially identical to the 125I-IbTx experiments I described previously: 14C-
IbTx was incubated with solubilized channels and the toxin-channel complex 
was recovered on treated glass filters, extensively washed in ice-cold buffer and 
14C β radiation was measured by scintillation counting (see Materials and 
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Methods section). hSLO1 and AcSLO1 channels purified from Sf9 showed robust 
IbTx binding using this assay: a representative example is shown in Figure 14, 
using toxin-sensitive AcSLO1T solubilized in DM. By using A280 to calculate the 
concentration of purified SLO1 used to set up these assays, I could quantify that 
at least ~60% of the expected receptors bound to 14C-IbTx in DM micelles. It is 
hard to know if this number means that a fraction of purified channels is in a 
toxin-insensitive state, or if it results from practical limitations of incomplete 
protein recovery on the glass filters and/or errors in estimating protein 
concentration (I used a theoretical calculation for the extinction coefficient ε280).  
For SLO1 channels expressed in Pichia, the results were drastically 
different: when the same experiments were performed, no binding could be 
detected (data not shown). This was further confirmed using the qualitative pull-
down assays on IbTx-coated resin. Whereas SLO1 expressed in Sf9 showed 
robust binding to the resin, no binding could be detected with Pichia-expressed 
channels (data not shown).  
 
2.2.5) Functional reconstitution of SLO1 channels expressed in Sf9  
 The IbTx-binding studies suggested that DM- or DDM-solubilized SLO1 
channels produced in Sf9, but not Pichia, could be purified in a native state. To 
further confirm the functional state of the purified proteins, I reconstituted these 
channels in lipid vesicles (POPE:POPG 3:1) and studied their function by 
electrophysiology in an artificial lipid bilayer system. SLO1 channels from Sf9 
were indeed fully functional since channel activity could be recorded (Figure 15). 
In the case of Pichia expression, I could never see any electrophysiological 
activity despite repeated reconstitution attempts (data not shown). Hence, it 
seems that only Sf9, and not Pichia, is suitable for the large-scale heterologous 






Figure 14: 14C-IbTx binding to purified 
AcSLO1T in DM micelles (from Sf9 
expression). Toxin-channel complexes 
were recovered by filtration. The 
experiment was set up with 100 nM 
channels. Each point is the mean of two 
measurements (shown ± range). Data 

















Figure 15: Electrophysiological recordings of reconstituted AcSLO1T from Sf9 
expression. Recordings were made in symmetrical 150 mM KCl, holding at + 150 mV. 






























AcSlo (mutant) in PE:PG bilayer
Purified channel reconstituted in lipid vesicles
Electrophysiology in artificial bilayer system
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expression of functional SLO1 channels (HEK cells are also an option, since SLO1 
from HEK expression binds IbTx in pull-down assays, as I presented in Figure 
13). This result was surprising and interesting, since Pichia is routinely used in 
our laboratory for the expression of eukaryotic K+ channels. I will discuss this 
finding in more details in the discussion section at the end of this chapter. 
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2.3 – PROGRESS TOWARDS A SLO CHANNEL STRUCTURE 
 
 
 Altogether, the functional studies on purified SLO1 showed that Sf9 insect 
cells are a suitable heterologous expression system for crystallographic studies of 
SLO channels. This works paves the way for the study of SLO channel atomic 
structure by X-ray crystallography. However, despite our endeavor, we have 
been so far unable to obtain crystals of AcSLO1 or hSLO1. As I will present in the 
next chapters, our immediate effort later switched to crystallographic studies on 
the SLO intracellular CTD, which led to important new insights on SLO channel 
functional and gating mechanisms. The crystal structure of a full SLO channel 
remains a major goal of research in our laboratory. In this section, I would like to 
quickly summarize results I obtained while trying to crystallize AcSLO1 or 
hSLO1, which I believe are significant for any future crystallization studies of 
SLO1 channels. 
 
2.3.1) SLO1 proteolysis and truncation studies  
 Purified SLO1 channels are quite sensitive to proteolysis. Even in a typical 
purification procedure, where special care is taken to limit proteolysis to a 
minimum (inclusion of a very diverse protease inhibitor cocktail during cell lysis, 
keeping the temperature at 4°C or below during all stages of purification), 
proteolytic cleavage can be seen (Figure 16a). Treatment with specific proteases 
further reveals this sensitivity. The example of limited proteolysis with 
chymotrypsin is shown in Figure 16a: no robust, proteolysis-resistant protein 
core can be seen on SDS-PAGE (the same applies to many other common 
proteases: trypsin, elastase, subtilisin, Glu-C, Lys-C and Arg-C).  
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 Sensitivity to proteolysis is often associated with the presence of poorly 
structured regions in a protein. SLO channels are very big proteins (~1100 
residues per monomer) and contain many loops between secondary structure 
elements that are expected to be surface-exposed and disordered (151). Such 
poorly structured regions are typically a problem for crystallization because they 
create structural heterogeneity at the protein surface. In limited proteolysis 
studies, I could identify the long linker (~100 amino acids, see Figure 16b) 
between RCK1 and RCK2 as a major proteolytic site (data not shown). 
Interestingly, it is known that most of this linker can be removed without 
affecting channel function by co-expressing in trans a construct containing the 
transmembrane and RCK1 domains together with a construct containing RCK2 
on its own (a simple deletion within a single construct does not work, surely 
because the linker bridges together two very distant parts within the protein) 
(151, 158). When I tested such co-expression with hSLO1 in HEK cells, the results 
looked fairly promising: the different domains assemble in the expected 
complete tetramer in a peak sharper than the wild-type protein itself (Figure 
16c).  
Additionally, I could show that the unstructured N- and C-termini as well 
as a long (~40 amino acids) unstructured loop in the middle of RCK2 could be 
removed without affecting the biochemical behavior of purified SLO1 (data not 
shown). Previous studies have shown that none of these parts are essential for 
function (151). Altogether, truncations of these parts, as well as truncation of the 
RCK1-RCK2 linker in a co-expression strategy, could facilitate crystallization by 




























Figure 16: SLO1 proteolysis and RCK1-RCK2 linker deletion. 16a) AcSLO1 limited 
proteolysis. SDS-PAGE showing purified AcSLO1 from Sf9 expression. Adding 
increasing concentrations of chymotrypsin does not reveal an obvious stable, protease 
resistant core. 16b) The long RCK1-RCK2 linker is a major proteolytic site. 16c) The 
RCK1-RCK2 linker can be removed using a strategy where two moieties of the SLO1 
molecule are expressed in trans (insets). Shown are FSEC profiles from hSLO1 
expression in HEK cells (Superose 6 column). The two traces are at the same scale. Upon 
linker removal, the whole hSLO1 channel still assembles as a proper tetramer. 
Interestingly, the hSLO1 tetramer elutes as a peak sharper that wild-type. The species 
eluting after 16 mL contain excess RCK2-GFP and free GFP.  
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2.3.2) Effect of divalent cations on SLO1 gel filtration behavior 
 The addition of ligand can often stabilize a purified protein. Ca2+ of 
course, but also Mg2+, activate SLO1 (21). Adding high concentrations of Ca2+ and 
Mg2+ improved the behavior of purified SLO1 on gel filtration (Figure 17). I have 
not studied this effect in a systematic way, but the presence of divalent cations 
could be important for the stability of purified SLO1. 
 
2.3.3) Choice of detergent for purification 
 The right choice of detergent, specific to each membrane protein, is often 
crucial for crystallization (186). I compared the gel filtration behavior of purified 
SLO1 channels in a large array of different detergents. Alkyl and Cymal 
maltosides, as well as polyoxyethylene glycol detergents gave similar gel 
filtration profiles, whereas glucosides (typically more dispersive) made the 
protein unstable (data not shown). Interestingly, the use of zwitteronic 
detergents such as amine-oxides or zwittergents improved gel filtration 
behavior. In particular, the profiles in LDAO or Zwittergent 3-12 seemed quite 
promising (Figure 20). Importantly, the elution volumes in LDAO or Zwittergent 
3-12 suggested that SLO1 channels were still tetrameric in these detergents. 
However, functional studies need to be performed to insure that the use of these 
detergents preserves the channels in a functional state.  
  













Figure 17: Effect of Ca2+ and Mg2+ on purified SLO1 gel filtration profile. Shown are 
gel filtration profiles (Superose 6 column) of purified AcSLO1 from Sf9 expression. The 
two samples come from the same protein preparation. Addition of high concentration of 
divalents cations (Ca2+ and Mg2+) improves the gel filtration behavior of AcSLO1: the 














Figure 18: Comparing detergents for SLO1 solubilization. Shown are gel filtration 
profiles of purified AcSLO1 solubilized in DM, Zwittergent 3-12 or LDAO. All samples 
come from the same protein preparation. Zwitterionic detergents (Zw. 3-12, LDAO) 
improve the gel filtration behavior of AcSLO1. 
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2.4 – DISCUSSION 
Expression of SLO channels in heterologous systems and purification 
 
 
  In summary, I have explored the heterologous expression of SLO channels 
in three different systems: HEK, Pichia and Sf9 cells. Initial screens revealed that 
human and Aplysia californica SLO1 channels are promising targets for 
crystallization efforts. Large-scale expression in Pichia and Sf9 led to the 
purification of milligram quantities of tetrameric hSLO1 or AcSLO1 solubilized 
in DM or DDM micelles. However, quantitative toxin binding studies revealed a 
major difference between these two expression systems. Purified SLO1 from Sf9 
expression bound IbTx, and electrophysiological studies on reconstituted 
proteins confirmed that the channels are indeed fully functional. On the other 
hand, SLO1 channels purified from Pichia expression did not bind IbTx and 
showed no functional activity when reconstituted in lipid membranes. What 
could explain this discrepancy? 
 I can think of three possibilities that would explain the absence of toxin 
binding and functional activity of SLO1 purified from Pichia: 1) Pichia yeast cells 
are not able to process and fold SLO1 channels, which only exist in the Metazoa 
kingdom. However, the fact that SLO1 from Pichia expression have their 
expected oligomeric form would suggest that this possibility is unlikely. 
Furthermore, the gel filtration behavior of proteins expressed in Pichia and Sf9 is 
identical; 2) SLO1 from Pichia expression actually co-purifies with a yeast-specific 
contaminant that impedes toxin binding and functional activity. In theory, a 
small molecule binding strongly to the channel’s extracellular mouth could 
physically prevent toxin binding and occlude ion flow. I have not studied 
whether any such species is present in the SLO1 purified samples, but this could 
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be done, for example by using mass spectrometry. This second explanation 
seems quite improbable, but cannot be entirely ruled out; 3) SLO1 function as 
well as toxin binding require the presence of a specific cofactor, for example from 
the cell membrane, that is lacking is yeast cells. This third possibility is by far the 
most reasonable.  
 The membrane composition of yeast cells is quite different from that of 
animal cells. For example, yeast completely lack cholesterol, which is an essential 
component of animal membranes. Instead, the yeast membrane is rich in another 
sterol, ergosterol (191). Studies of mammalian G-protein coupled receptors 
(GPCR) have shown that ergosterol and cholesterol, even though very similar in 
structure, do not have the same functional properties. In the case of the human µ-
opioid GPCR, ergosterol cannot be substituted for cholesterol to promote protein 
function, and µ-opioid receptors are expressed in yeast in an inactive form, 
which does not bind classical agonists (192). Interestingly, adding cholesterol to 
the yeast membrane restores agonist binding and function (192). This example 
illustrates how the functional properties of membrane proteins expressed in 
yeast can be impaired by the singular composition of the yeast lipid membrane. 
No specific lipid requirement for SLO1 function has been described, but 
cholesterol itself could be a candidate. It is indeed interesting that digitonin, 
which is known to directly interact with cholesterol (and presumably solubilizes 
membrane proteins along with a small cholesterol-containing patch of 
membrane), has a very unique effect on SLO1 solubilization. Overall, probing 
whether SLO1 channels interact with specific components of the cell membrane 
is an important physiological question. The methods I developed, which for the 
first time allow large-scale purification of functional SLO1 channels, could open 
the way for such studies by providing an experimental system in which the 
precise molecular composition can be controlled.  











CRYSTAL STRUCTURES OF THE CA2+-BOUND SLO1 
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 While still working on crystallizing a full-length SLO channel, we decided 
to also explore another strategy. As I described in Chapter 1, the gating of SLO 
channels by intracellular signals (Ca2+ for SLO1, Na+ for SLO2, pH for SLO3) is at 
the core of their physiological functions. Since intracellular activation of SLO 
channels is controlled by their large cytoplasmic domain (CTD) (23), we decided, 
together with my close collaborator and mentor Peng, to study the atomic 
structure of isolated CTDs from different SLO channels using X-ray 
crystallography. We reasoned that this structural information could teach us a lot 
about the molecular basis of SLO channel gating. In particular, we wanted to 
specifically address two questions: What kind of conformational change occurs 
in the CTD upon ligand binding or pH change in order to promote channel 
opening? How do the activation mechanisms of SLO1, SLO2 and SLO3 compare 
to one another? 
 To this end, Peng and I decided to screen SLO1, SLO2 or SLO3 CTDs from 
different species to identify the best candidates for crystallization. Based on the 
results from expression of full-length channels, we expressed constructs in Sf9 as 
C-terminal PreScission-GFP-His10 fusions. Most CTDs we tested could be readily 
expressed. Together, we identified several promising targets from SLO1, SLO2 
and SLO3 that crystallized in initial screens. Refining these crystals to diffraction-
quality was challenging, and we decided to share the effort. Peng focused on 
SLO1, whereas I concentrated on SLO3.  
 Together with our co-worker Hsiung, who helped us with cell culture, 
and under Rod’s continuous guidance, we solved three CTD crystal structures: a 
monomeric, Ca2+ bound structure of the human SLO1 (hSLO1) CTD (published 
in (193)); a tetrameric, Ca2+-bound structure of the zebrafish SLO1 (zSLO1) gating 
ring (published in (194)); and a tetrameric structure of the human SLO3 (hSLO3) 
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gating ring. In this chapter, I will describe the structures we obtained of the SLO1 
CTDs.  
 The first structure we solved, the monomeric hSLO1 CTD, defines for the 
first time the precise molecular organization of a SLO channel intracellular 
domain. Even though in our crystals the hSLO1 CTDs did not assemble in a 
gating ring, we could infer the tetrameric, functional organization of the hSLO1 
domains by using low-resolution diffraction data from a SLO2.2 crystal. This 
oligomeric assembly was later confirmed by the structure of the hSLO1 gating 
ring solved by the laboratory of Youxing Jiang at UT Southwestern. This 
structure, solved in the absence of Ca2+, defines the ligand-free, “closed” 
conformation of the SLO1 gating ring. To understand how the binding of Ca2+ in 
the SLO1 CTD changes the conformation of the protein, we solved the tetrameric 
gating ring structure of the zebrafish SLO1 CTD bound to its ligand. I will show 
how, together, these results illustrate how a Ca2+-driven conformational change 
in the SLO1 CTD could translate into the opening of the channel transmembrane 
pore. 
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3.1 – STRUCTURE OF THE HUMAN SLO1 CA2+ ACTIVATION APPARATUS 
  
 
3.1.1) Crystallization and structure determination 
 Residues 341 to 1056 of the human SLO1 sequence were expressed in Sf9 
cells. This construct comprises the entire hSLO1 CTD, from the expected first 
structural element, with the exclusion of 57 amino acids at the very C-terminus 
that are predicted to be unstructured and are not essential for function (151). The 
protein was purified and crystallized in the presence of a high concentration of 
Ca2+ (50 mM). The native crystals diffracted X-rays to a resolution of 3.0 Å and 
belonged to space group P6322, with one monomer per asymmetric unit. 
Experimental phases to 3.3 Å were derived from a multi-wavelength anomalous 
diffraction experiment with a selenomethionine-containing crystal, and the final 
structure was refined to Rwork/Rfree = 0.25/0.28 (Table 1).  
 
3.1.2) Global structure of the hSLO1 CTD 
 The hSLO1 CTD crystallized in a monomeric form. The structure, shown 
in Figure 19a, reveals for the first time the precise molecular organization of the 
SLO1 intracellular domain. In particular, the structure shows unequivocally that 
the hSLO1 CTD is formed by a tandem of RCK domains (RCK1 shown in blue, 
RCK2 in red), as was originally predicted by sequence analysis (24, 122, 151) but 
was still matter of debate in the field (195). A salt-bridge interaction between the 
side chains of K448 and D481, which was originally identified as a signature of 
the presence of RCK1 in the SLO1 CTD (24), can be seen in the structure (Figure 
19a). Similar to what is seen in the bacterial MthK channel, each RCK domain has 
a bi-lobed shape (Figure 19b): a large N-terminal lobe with a Rossman fold, and a 
smaller C-terminal lobe. These two lobes are linked by a helix-turn-helix 
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connector (αF-αG in RCK1 and αS-αT in RCK2) that forms the main interface in 
the RCK1-RCK2 tandem (Figure 19c). This interface is reminiscent of the “flexible 
interface” created through the dimerization of two separate identical RCK 
domains in MthK (122).  
 
3.1.3) The Ca2+ bowl 
 Because of the uncertainty and disagreement in sequence-based models of 
the SLO1 channel CTD, there have been different proposals for the placement of 
the main SLO1 Ca2+ binding site, the Ca2+ bowl, in RCK2 (151, 195). The hSLO1 
CTD structure reveals for the first time the precise location of the Ca2+ bowl 
(889QFLDQDDDDDPD900) between the last two β strands (βO and βP, see 
Appendix A) of the RCK2 N-terminal lobe. Interestingly, the position of the Ca2+ 
bowl within the hSLO1 CTD is in sharp contrast with the Ca2+ binding sites of 
MthK (Figure 19d). Whereas in MthK Ca2+ binds on the RCK1-RCK2 “flexible 
interface”, in hSLO1 the Ca2+ bowl is positioned on the side of RCK2 (Figure 19a).  
The experimental electron density for the Ca2+ bowl contained less detail 
than most of the experimental map, but the main chain was continuous, and 
certain side chain features emerged with cycles of model building and 
refinement (Figures 20a, 20b). The model was built on the basis of 
crystallographic data alone, independently of information from prior mutational 
studies. Interestingly, an atom that is more electron-dense than carbon, nitrogen, 
or oxygen accounted for the strongest electron density at the center of the Ca2+ 
bowl (Figure 20b): we attributed this density as a Ca2+ ion, given its presence at 
50 mM concentration in the crystallization solution. Atoms making direct contact 
with the Ca2+ ion include two main-chain carbonyl oxygen atoms from Q889 and 
D892 and oxygen atoms from the side-chain carboxylate groups of D895 and 



























Figure 19: Monomer structure of the human SLO1 CTD. 19a) Cartoon representations 
of the hSLO1 CTD showing RCK1 in blue and RCK2 in red. The Ca2+ bowl is colored in 
green, and the Ca2+ ion is shown as a yellow sphere. Large disordered segments are 
indicated as dashed lines. The N-terminal residue (K343), connecting to the 
transmembrane ion-conduction pore, is shown as a magenta sphere. 19b) Sub-domain 
organization of RCK1. The organization of the RCK2 domain is identical. 19c) Close-up 
view of the αF-αG/αS-αT “flexible” interface. 19d) Ca2+ binding sites in the bacterial 
MthK channel (PDB ID 1LNQ). 
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Figure 20: The Ca2+ bowl. 20a) Experimental electron density at 3.3 Å in the Ca2+ bowl 
region contoured at 1.0 σ. 20b) Weighted 2Fo-Fc electron density at 3.0Å after 
refinement contoured at 1.0 σ and 4.0 σ. The final refined model is shown as sticks, with 
most side chains removed for clarity. 20c) Structure of the Ca2+ bowl, showing key 
residues coordinating the Ca2+ ion (yellow sphere). 20d) Superposition of the Ca2+ bowl 
and the Ca2+ binding site from the calpain-1 catalytic subunit (blue) (PDB ID 2R9F). The 
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D897 (Figure 20c). In searching the protein database of known structures, we 
observed a similar geometry of Ca2+ binding in a high-resolution crystal structure 
of calpain, which is an intracellular cysteine protease whose activity is regulated 
by Ca2+ (Figure 20d). 
 Our unbiased model for the Ca2+ bowl structure explains very well the 
results of in-depth Ala scanning mutagenesis studies of this region (1). The two 
most critical residues for Ca2+ activation, D895 and D897, are both directly 
involved in the coordination of the Ca2+ ion in the X-ray structure (Figure 20c). 
The third most effective mutation involved D894, which is not in direct contact 
with Ca2+ but forms salt bridges simultaneously with R1018 and K1030 in the C-
terminal lobe of RCK2. D894 probably plays an important role in stabilizing the 
conformation of the Ca2+ bowl. The mutation D896A, on the other hand, had 
almost no effect on the channel’s sensitivity to Ca2+ (160). In the X-ray structure, 
this side chain is directed out and away from the Ca2+ ion and does not make 
other protein contacts. 
 
3.1.4) Quaternary assembly of the hSLO1 gating ring 
 In our hSLO1 crystals, the CTD is monomeric. However, we expected, by 
comparison with RCK-containing bacterial channels such as MthK, that in a 
SLO1 channel the CTDs from the four subunits assemble in a tetrameric “gating 
ring” at the intracellular face of the membrane (21, 122). Can we infer, from our 
monomeric hSLO1 CTD structure, the quaternary assembly of the hSLO1 gating 
ring?  
 To address this question, we used data from another SLO CTD that we 
could crystallize: the Na+-activated chicken SLO2.2 (gSLO2.2) CTD. We purified 
and crystallized the gSLO2.2 CTD (amino acids 347 to 1201) in the presence of 
500 mM Na+. On gel filtration, the CTD eluted as a tetramer, and even under the 
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dispersive conditions of SDS-PAGE, the majority of protein migrates as a 
tetramer. Thus, the gSLO2.2 CTD forms a very stable tetrameric complex. The 
crystals diffracted X-rays to a resolution of 6 Å and were of space group I422, 
with one monomer (subunit) in the asymmetric unit (Table 1). Using a poly-Ala 
model of the hSLO1 CTD, we obtained a single outstanding solution in 
molecular replacement against the gSLO2.2 diffraction data. This solution 
indicates that the hSLO1 and gSLO2.2 CTDs must have very similar structures. 
By applying the crystallographic symmetry operators, we obtained the tetramer 
structure of the hSLO1 CTD (Figure 21a). This objective solution reveals the 
quaternary organization of subunits but not its exact atomic details because the 
resolution is low and the data are from the SLO2.2 homolog. 
Importantly, the biological relevance of the SLO1 gating ring assembly is 
supported by previous functional studies. The “assembly interface” between 
RCK1 and RCK2 from two adjacent hSLO1 subunits has been studied by double-
mutant cycle mutagenesis, and several amino-acid pairs have been shown to 
interact (151, 196). These amino acid pairs, including I441-L822, M442-L825, and 
I445-L825, are far away from each other in the monomer but are brought close 
together in space in the hSLO1 gating ring (Figure 21b).  
 A comparison of the gating rings from MthK and hSLO1 reveals a striking 
difference between the two proteins: whereas in MthK Ca2+ binds at the “flexible 
interface” within a RCK pair in the same subunit, in SLO1 the Ca2+ bowl is 
located at the “assembly interface” between two adjacent subunits (Figures 21a 
and 21c). This result emphasizes the profound functional differences between 
































Figure 21: Gating ring assembly of hSLO1. 21a) Orthogonal views of the tetrameric 
hSLO1 gating ring structure using 6.0 Å diffraction data from the homologous chicken 
SLO2.2 CTD. View on the right is down the fourfold symmetry axis, with RCK1 in blue 
and RCK2 in red. The Ca2+ ions are shown as yellow spheres. The flexible and assembly 
interfaces are labeled. 21b) Close-up view of the assembly interface. 21c) Open gating 
ring structure from the MthK channel (PDB accession, 1LNQ), viewed down the 
fourfold axis. 
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3.1.5) Structure of the Ca2+-free hSLO1 gating ring from the Jiang lab 
 Shortly after we published the structure of the monomeric Ca2+-bound 
hSLO1 CTD, the laboratory of Youxing Jiang solved the X-ray structure of the 
hSLO1 CTD in a gating ring form, in Ca2+-free conditions (197). To constrain 
tetramerization of the CTDs in the crystal, Jiang and co-workers fused the CTD 
N-terminus to a leucine-zipper domain from the GCN4 transcription factor that 
is known to assemble in a tetrameric coil-coiled helix bundle (197) (Figure 22a). 
Using this method, they obtained the tetrameric structure of the hSLO1 CTD 
gating ring at 3.1 Å resolution. Surprisingly, the tetrameric coil-coiled domain 
was disordered in the crystals, and could not be seen in the structure.  
 The hSLO1 gating ring structure of Jiang and colleagues (Figure 22b) 
matches extremely well with the tetrameric assembly we proposed based on the 
gSLO2.2 low-resolution data (193, 197). In particular, the inter-subunit “assembly 
interface”, whose atomic details are now defined, is in excellent agreement with 
our model. The Ca2+ bowl sequence in this new hSLO1 gating ring structure sits 
at the same assembly interface.  
 The hSLO1 gating ring structure was solved in the absence of Ca2+, thus 
representing the unliganded, most likely “closed” conformation of the SLO1 
gating ring (197). This important structure therefore provides the first 
conformational snapshot of a eukaryotic SLO channel gating ring. Since this 
structure defines the Ca2+-free, closed conformation of the SLO1 gating ring, the 
next important question to answer was how the binding of Ca2+ influences the 
structure of the SLO1 gating ring to promote channel opening. To address this, 
we focused our effort on finding conditions to obtain the crystal structure of a 
Ca2+-bound SLO1 gating ring. Screening for SLO1 CTDs from many different 
species, we discovered that the CTD from the zebrafish SLO1 could be 
crystallized in the presence of Ca2+, assembling in a gating ring.  




Figure 22: hSLO1 Ca2+-free, closed gating ring structure. 22a) 
Schematic representation of the strategy used by Jiang and 
colleagues to stabilize the tetrameric assembly of the hSLO1 
CTD: the CTD is fused to a helix from the GCN4 protein forming 
a very stable tetrameric coil-coil bundle. 22b) Orthogonal views 

























Figure 23: zSLO1 Ca2+-bound, open gating ring structure. Orthogonal views of the Ca2+-
bound, open zSLO1 gating ring structure, using the same scale and orientation as in 
Figure 22b, The Ca2+ bowl is shown in green and Ca2+ ions as yellow spheres. 
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3.2 – STRUCTURE OF THE CA2+-BOUND, OPEN SLO1 GATING RING 
 
 
3.2.1) Crystallization and structure determination 
 We used a CTD construct from the zebrafish SLO1 (zSLO1) channel 
containing two truncations (194): a truncation removing the disordered C-
terminus (as in hSLO1) and a deletion of a large loop in RCK2 that was surface-
exposed and disordered in our previous hSLO1 structure (193). We verified that 
these two deletions had no effect on the function of the full channel (194). The 
protein crystallized in the P212121 space group, with eight CTD copies in the 
asymmetric unit. The crystals diffracted X-rays to 3.6 Å resolution. Initial phases 
were determined by molecular replacement using our previous hSLO1 CTD 
structure as a search model, and refinement using 8-fold crystallographic 
symmetry restraints led to a final model with Rwork/Rfree = 0.26/0.29 (Table 2). 
 
3.2.2) Open structure of the SLO1 gating ring 
 An important aspect of the zSLO1 gating ring structure is the fact that the 
human and zebrafish SLO1 channels are extremely close in both amino acid 
sequence and functional properties. The two channels are 93% identical in terms 
of sequence, and their sensitivities to Ca2+ are essentially indistinguishable (data 
not shown). As a consequence, the ligand-bound, “open” zSLO1 gating ring 
structure can be directly compared to the Ca2+-free, “closed” hSLO1 gating ring 
structure to assess potential conformational changes underlying Ca2+-mediated 
gating.  
 The overall organization of the open zSLO1 gating ring is similar to the 
closed gating ring structure: the RCK1 domains from each subunit form a layer 
of the gating ring closest to the membrane, whereas a layer of RCK2 domains 
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assembles below (Figure 23). Electron density attributable to a Ca2+ ion is present 
in the Ca2+ bowl region, at the “assembly interface” between subunits, 
confirming the location of this Ca2+ binding site we originally inferred. The Ca2+ 
bowl structure itself is nearly identical to that of the monomeric Ca2+-bound 
hSLO1 CTD (data not shown). 
 
3.2.2) RCK1 N-lobe movement in the closed-to-open transition 
 What are the main structural differences between the Ca2+-free, closed and 
the Ca2+-bound, open SLO1 gating rings (shown in Figure 24a)? An objective 
comparison of conformational differences between the two structures is achieved 
by superimposing all Cα atoms of the tetrameric gating rings. Such a 
superposition reveals that most of the gating ring undergoes very little 
conformational change, especially the bottom RCK2 layer. In particular, only 
modest conformational differences occur at the intersubunit “assembly 
interface”, except locally near the Ca2+ bowl (Figure 24b). However, the 
architecture of one region of the protein changes significantly between the closed 
and open structures: the top of the RCK1 layer facing the membrane, 
corresponding to the very N-terminal part of the CTD (from secondary structure 
elements βA to βC) in the RCK1 N-lobe. This conformational change is shown in 
more detail in Figure 24c, where the moving N-terminal region of the gating ring 
is highlighted in blue (the rest of the protein is colored in grey, and the front 
subunit is removed for clarity): in the Ca2+-bound, open structure, the N-lobe 
region of the RCK1 layer moves upward. Importantly, the moving RCK1 N-lobe 
region contains the N-terminal CTD residue (Lys 343 in both hSLO1 and zSLO1, 
Cα shown as magenta sphere), which is connected to the transmembrane pore in 
the channel. It is interesting to note that the Ca2+ ion bound in the Ca2+ bowl is 
not directly at the interface between the moving βA-βC RCK1 N-lobe region and 
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the rest of the protein (Figure 24d). The overall conformational changes between 
the closed an open gating rings are best appreciated by looking at an 
interpolative movie where both structures are morphed (movie available at: 
http://tinyurl.com/7zx3bwb, part 1): the RCK1 N-lobes appear to “open up” on 
the membrane-facing surface of the gating ring in a way akin to petals opening 
on a flower. The upward movement of the RCK1 N-lobe between the closed and 
open conformations results in a significant increase in the diameter of the SLO1 
gating ring (at the position of the N-terminal residues). This is shown in Figure 
24e: the bulk of the protein (where conformational changes are only modest) is 
colored in grey, the N-terminal region of the RCK1 N-lobes is colored in blue and 
the Cα of Lys 343 is shown in magenta. The gating ring diameter, measured at 
the Lys 343 Cα, increases from 81 Å in the closed SLO1 to 93 Å in the open SLO1. 
Such dilation of the gating ring is reminiscent of what is seen between the closed 
and open conformations of the bacterial Ca2+-activated MthK (see Chapter 1).  
 Again, the remodeling occurring at the inter-subunit interface upon Ca2+ 
binding is only modest. Instead, the major conformational change of the SLO1 
gating ring during the closed-to-open transition is created principally by a 
structural rearrangement within individual subunits. The structures of single 
subunits from the Ca2+-free hSLO1 and Ca2+-bound zSLO1 are compared in 
Figure 25. In Figure 25b, the RCK2 domain is chosen as a point of reference to 
illustrate this intra-subunit rearrangement: the subunit structures are superposed 
by minimizing the distances between Cα atoms in the RCK2 domain (see Figure 
25c where Cα distances are plotted onto the open subunit structure). We can see 
that the major conformational change involves the RCK1 N-terminus (βA to βC 
in the RCK1 N-lobe), which changes its angle and orientation with respect to rest 
of the structure.   























Figure 24: Conformational changes between the closed and open SLO1 gating rings 
structures. 24a) Structure of the Ca2+-bound, open gating ring illustrating the result of an 
all-atom superposition with the Ca2+-free, closed gating ring. The open gating ring 
structure is colored according to the distance between corresponding Cα positions in the 
two structures. In the side view (left), the front subunit is removed for clarity. 24b) 
Superposition of the assembly interfaces from the closed (grey) and open (colored) 
gating ring structures. 24c) Comparison of the closed and open structures using the 
same side view as in 24a. The structures are show in grey, except the βA-βC region of 
the RCK1 N-lobe, which is highlighted in blue (see text). The N-terminal Lys 343 is 
shown as magenta sphere. 24d) Close-up view of the assembly interface and the βA-βC 
region of the RCK1 N-lobe. 24e) Closed and open SLO1 gating rings structures viewed 
from the top, down the four-fold symmetry axis. The diagonal distance between the Cα 






























Figure 25: Conformational changes between subunits from the closed and open SLO1 
structures. 25a) Structure of a subunit from the Ca2+ bound, open SLO1 gating ring. The 
N-terminal Lys 343 is shown as magenta sphere. 25b) Same views as in 25a) showing a 
superposition of subunits from the open (in red) and closed (in black) SLO1 gating rings, 
aligning the RCK2 domains. Parts where the two structures align very well are shown in 
wire representation. The βA-βC region of the RK1 N-lobe, which orientation changes 
significantly between the two structures, is highlighted by showing a cartoon 
representation of secondary structure elements. The N-terminal Lys 343 is shown as a 
sphere. 25c) Cartoon representation of the open SLO1 subunit colored according to the 
distance between Cα positions between the open and closed structures in the 
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3.3 – A STRUCTURAL MODEL FOR SLO1 CA2+-DRIVEN OPENING 
 
 
 Are the conformational changes we observe between the Ca2+-free and 
Ca2+-bound SLO1 gating ring structures compatible with the opening and closing 
of a K+ channel? In other words, with these two conformations in hand, can we 
reconstruct the transition between a closed and an open SLO1 channel using our 
prior structural knowledge of K+ channels? 
 To address this question, we constructed structural models of the closed 
and open conformations of a SLO1 channel using the SLO1 gating ring structures 
and the structures of closed (KcsA) and open (MthK) bacterial K+ channel pores. 
The Ca2+-bound structure of MthK served as the first reference for our model. We 
started with this open MthK structure and replaced its gating ring with the Ca2+-
bound zSLO1-channel gating ring. This step involved alignment of the four-fold 
axis followed by minimization of the distance between the N terminus of the 
SLO1 gating ring and the corresponding position within the MthK gating ring 
structure, through least-squares minimization of the distances between residues 
343 of all four SLO1 subunits and the corresponding residues, 116, of all four 
MthK subunits. The resulting model of an open SLO1-channel gating ring with 
an open K+ pore is shown in Figure 26a. The distance between the C-terminal 
residue of the inner helix of the pore and the N-terminal residue of RCK1, which 
was not constrained in making the model, is 33 Å. In a second step, we replaced 
the open MthK pore with the closed KcsA pore by aligning the invariant 
selectivity filter, and replaced the Ca2+-bound zSLO1 gating ring with the Ca2+-
free hSLO1 gating ring by aligning the nearly invariant RCK2 layer. The 
resulting model of a Ca2+-free SLO1 gating ring with a closed K+ pore is shown in 
Figure 26b. In this closed model, the distance between the C-terminal residue of 
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the inner helix and the N-terminal residue of RCK1, which again was not 
constrained in making the model, is 32 Å. In this analysis, the similar pore-to-
gating-ring distance (32 Å) in the open model and the closed model suggests that 
the magnitude of conformational change observed within the gating ring is 
compatible with the magnitude of change known to occur in the pores of other 
kinds of K+ channels. This result reinforces the conclusion that the Ca2+-free 
hSLO1 and Ca2+-bound zSLO1 gating ring structures represent two 
conformations directly relevant to Ca2+-driven gating in SLO1 channels. An 
interpolative movie illustrating our analysis is available at 
http://tinyurl.com/7zx3bwb (part 2). 
 
 
 Altogether, the SLO1 CTD structures we solved offer important new 
insights into the mechanism of Ca2+ gating in SLO1 channels. The first structure 
of the monomeric hSLO1 CTD describes the precise molecular organization of 
the SLO1 Ca2+-activation apparatus, formed by a tandem of RCK domains. The 
structure also defines the precise position of the Ca2+ bowl, on the side of RCK2, 
which has an unexpected structural consequence: in SLO1 channels, this main 
Ca2+ binding site is located at the assembly interface between subunits, in sharp 
contrast with the position of the ligand binding site in bacterial RCK-containing 
channels. By solving the structure of the Ca2+-bound zSLO1 gating ring, and 
comparing it with the structure of the Ca2+-free hSLO1 gating ring from the Jiang 
lab, we now have the first molecular snapshots of the conformational changes 
involved in SLO1 Ca2+-driven opening. During the closed-to-open transition, a 
major conformational change occurs in the RCK1 N-lobes facing the membrane, 
leading to a dilation of the gating ring that we can directly link to the opening of 
the transmembrane K+-conducting pore.   






Figure 26: A Ca2+-gating model for the SLO1 channel. 26a) Views of the SLO1 channel 
model with an open gating ring and an open pore. The structure of the Ca2+-bound SLO1 
gating ring is docked onto the open MthK channel (PDB accession 1LNQ) by aligning 
the gating rings. Yellow spheres represent Ca2+ ions. The N-terminal residues of RCK1 
and the C-terminal residues of the inner helices are shown as black spheres. 26b) Views 
of the BK channel model with a Ca2+-free gating ring and a closed pore. Here, the Ca2+-
bound gating ring in 26a) is replaced by the Ca2+-free gating ring (PDB accession 3NAF) 
and the open MthK pore in 26a) is replaced by the closed KcsA pore (PDB accession 
1K4C). The inner helix from KcsA is truncated to match the length in MthK.  
  
binding causes a shrinking of the ring’s height and an expansion of
its diameter12 (Supplementary Movie 2). By contrast, in the BK gating
ring Ca21 binding causes only the layer facing the membrane to
undergo a substantial conformational change (SupplementaryMovie 1).
This comparison presents a fascinating example in which the evolution
of molecular structure has given rise to new or modified mechanical
properties within a class of molecules. Precisely how the free energy of













Flexible interface Flexible interface











Figure 2 | The flexible interface and the assembly interface. a, The flexible
interface from the open gating ring, with RCK1 in blue and RCK2 in red. The
Ca21 ions are shown as yellow spheres. The N- and C-terminal lobes of RCK1
and RCK2 are labelled. Large disordered regions are indicated by dotted lines.
b, The flexible interface from the closed gating ring, with RCK1 in blue and
RCK2 in red (PDB accession 3NAF). c, Superposition of the assembly interfaces
from the open and closed gating ring structures. Secondary structural elements
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Figure 3 | A Ca21-gating model for the BK channel. a, Views of the BK-
channel model with an open gating ring and an open pore. The structure of the
Ca21-bound BK gating ring is docked onto the open MthK channel (PDB
accession 1LNQ) by aligning the gating rings. Yellow spheres represent Ca21
ions. TheN-terminal residues of RCK1 and theC-terminal residues of the inner
helices are shown as black spheres. b, Views of the BK channel model with a
Ca21-free gating ring and a closed pore. Here, the Ca21-bound gating ring in
a is replaced by the Ca21-free gating ring (PDB accession 3NAF) and the open
MthK pore in a is replaced by the closedKcsA pore (PDB accession 1K4C). The
inner helix from KcsA is truncated to match the length in MthK. See
Supplementary Movie 1.
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 This work paves the way for a precise molecular understanding of Ca2+ 
activation in SLO1 channels. In particular, we can now directly address how the 
energy of Ca2+ binding is transduced into the conformational changes we observe 
(and ultimately into mechanical work to open the channel pore) by designing 
specific experiments based on our structural knowledge. At another level, our 
data and analysis now define the precise conformation of two end points in the 
Ca2+-induced gating conformational transition of the SLO1 gating ring. Given the 
large conformational change that occurs upon Ca2+ binding, it should in principle 
be now possible to identify small molecules that stabilize one conformation or 
the other, with direct therapeutic implications considering the vast range of 
disorders linked to SLO1 function. 
  










CRYSTAL STRUCTURE OF THE HUMAN SLO3 CTD: 
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 Our work on SLO1 channels defined the conformational changes 
occurring at the intracellular level during Ca2+-activation: the upward movement 
of the RCK1 N-lobe region upon Ca2+ binding triggers opening of the 
transmembrane ion-conduction pore. What, then, about other channels in the 
SLO family? Are the mechanistic principles of intracellular activation conserved? 
To address this question, I turned to the pH-sensitive, alkalization-activated 
SLO3 channels, which are the closest homologs of SLO1 (see Chapter 1). I 
focused on the human and mouse SLO3 channels, aiming at understanding the 
molecular mechanisms of pH sensing in these proteins. To this end, I solved a 
structure of the human SLO3 gating ring. Interestingly, a comparison with the 
SLO1 gating ring structures reveals that the organization of the N-lobe region of 
the RCK1 domains in the tetrameric hSLO3 gating ring matches closely the open 
conformation of the SLO1 gating ring.  
To further understand the mechanistic principles of pH gating in SLO3 channels, 
I performed functional mutagenesis with the goal of identifying protein residues 
responsible for pH sensing. Whereas the direct functional analysis of the human 
SLO3 channel proved prohibitively challenging because of low protein 
expression, I could identify the residues responsible for pH sensing in the mouse 
SLO3 homolog. These residues are located at the interface between the RCK1 N-
lobe and RCK2. This lead me to propose a model for pH sensing in the mouse 
SLO3 channel in which the direct effect of pH increase is to drive the movement 
of the RCK1 N-lobes to open the channel. Surprisingly, the protein residues 
forming the pH sensor in mouse SLO3 are not conserved in SLO3 channels from 
other species. SLO3 channels, which are specific to mammalian sperm cells, offer 
a striking example of the extremely fast evolution of proteins specialized in 
reproduction. 
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4.1 – STRUCTURE OF THE HUMAN SLO3 GATING RING 
 
 
4.1.1) The human SLO3 channel is activated by an increase in intracellular pH 
 As I presented in Chapter 1, SLO3 channels are specific to mammalian 
sperm cells, where variations in intracellular pH directly regulate many 
physiological processes (32). So far, only the function of the mouse homolog of 
SLO3 has been studied in detail. Electrophysiological studies have shown that, in 
mouse sperm cells, SLO3 currents are activated by an increase in intracellular pH 
(1-3). Furthermore, the pH-dependence of mSLO3 currents has been 
characterized in depth using heterologous expression (95, 198). I became 
interested in the human SLO3 (hSLO3) homolog because of its direct relevance to 
human physiology, but hSLO3 channels had never been studied functionally. I 
therefore decided to first characterize the pH dependence of hSLO3 currents, 
using heterologous expression. 
 I expressed SLO3 channels in Xenopus laevis oocytes, a standard 
expression system for electrophysiological studies (199). Xenopus oocytes are 
extremely large single cells (>1 mm diameter) in which RNA coding for an ion 
channel (or other protein of interest) can be directly injected. The oocyte cellular 
machinery then induces expression of the channel, and the corresponding 
currents can be studied by electrophysiological techniques. To study intracellular 
activation of SLO3 channels I used the inside-out patch-clamp technique, where 
a patch of the oocyte membrane is isolated within a glass pipette in a 
configuration exposing its intracellular surface. The intracellular solution applied 
to such an “inside-out” patch can thus be controlled, while the corresponding 
electrical currents are recorded. 
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 The results of such recordings are presented in Figure 27a, which shows 
currents of a single inside-out patch from an hSLO3-expressing oocyte. The 
currents are elicited by a series of voltage steps from -140 to + 180 mV. Clearly, 
the hSLO3 currents are pH-sensitive: as the intracellular pH is increased, the 
current density increases as well. For comparison, the same experiment 
performed on the mouse mSLO3 homolog is shown in Figure 27b. Plotting the 
maximum SLO3 current (i.e., at +180 mV) as a function of H+ concentration 
reveals that the pH dependences of hSLO3 and mSLO3 channels are extremely 
similar (Figure 27c). However, comparing the total amount of current between 
hSLO3 and mSLO3 reveals an important difference between these two channels: 
in Xenopus oocytes, hSLO3 channels are poorly expressed compared to mSLO3 
(compare the current scale between Figures 27a and 27b). This property makes 
the functional analysis of hSLO3 technically challenging. Using other expression 
systems (HEK cells or Sf9 cells) for electrophysiology did not overcome this 
problem (data not shown). In HEK cells, tagging hSLO3 with GFP shows an 
accumulation of GFP signal in the peri-nuclear region, suggesting that the hSLO3 
protein is difficultly expressed at the plasma membrane (data not shown). 
 These functional studies on human SLO3 channels expressed in Xenopus 
oocytes establish for the first time that hSLO3 currents are alkalization-activated, 
with a pH-dependence very similar to the well-studied mSLO3 homolog. 
 
4.1.2) Crystallization of the hSLO3 CTD and structure determination 
 Based on these results, I became interested in understanding the 
molecular mechanisms of pH sensing in mouse and human SLO3 channels. To 
this end, I decided to study the structure of cytoplasmic domains (CTDs) from 
these channels, expressed in Sf9 cells as described in Chapter 3. Only the hSLO3 
CTD could be expressed at levels compatible with structural analysis 



























Figure 27: pH activation of human and mouse SLO3 channels. 27a) Representative 
inside-out patch currents recorded from a Xenopus oocyte expressing human hSLO3 
channels. Channel opening was elicited by voltage pulses from -140 to +180 mV in 20 
mV increments (see inset, holding voltage: -60 mV). The hSLO3 patch was sequentially 
bathed in solutions of increasing pH. The capacitive currents are masked for clarity. 27b) 
Recordings as in 27a), showing currents from a mouse mSLO3 patch. 27c). 27c) Plot of 
maximal current at +180 mV as a function of intracellular [H+], normalized to current at 
pH 8.5. Error bars show the standard error of the mean (hSLO3, n=3; mSLO3, n=5). pH 
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 (interestingly, the relative expression levels of the CTDs from hSLO3 and 
mSLO3 is opposite the expression levels of the whole channels).  
 Preliminary biochemical analysis showed that the hSLO3 CTD is most 
stable at high pH, and assembles as a tetramer during purification (data not 
shown). Crystals were obtained using poly-ethylene-glycols (PEGs) as 
precipitants, and PEG chain length was critical to optimize diffraction. The best 
crystals were grown using PEG12000 and diffracted X-rays to ~3.3 Å resolution. 
The hSLO3 CTD crystallized in the I222 space group, containing two CTD 
subunits in the asymmetric unit.  
 Diffraction of X-rays by these crystals was very anisotropic, and analysis 
revealed that diffraction in the a* and b* directions of the reciprocal cell are the 
weakest. The final dataset I used for structure determination makes use of data 
recorded from two different crystals, which varied in their degree of anisotropy. 
Reflection data were merged and scaled together in the final dataset. The scaled 
dataset was anisotropically corrected to resolution limits of 3.8, 3.4 and 3.3 Å 
along the reciprocal cell directions a*, b*, and c*, respectively, using the 
diffraction anisotropy server at UCLA (200). The final model was refined against 
data to 3.4 Å resolution. 
 The structure was solved by molecular replacement using the monomeric 
hSLO1 CTD structure as a search model. Importantly, the first step of structure 
refinement required rigid-body adjustment of the RCK1 N-lobe. The final model 
was refined to Rwork/Rfree = 0.25/0.27 (Table 3). Application of the 
crystallographic symmetry operators revealed that the hSLO3 CTDs assemble in 
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4.1.3) Structure of the hSLO3 gating ring 
 The structure of the hSLO3 gating ring is shown in Figure 28a. The overall 
domain organization is similar to the SLO1 gating structures: in the hSLO3 
gating ring, RCK1 domains form an upper layer facing the membrane (with the 
RCK1 N-lobe regions at the top) and RCK2 domains form a layer at the bottom. 
The secondary structure elements forming the “assembly interface” between 
subunits are conserved between hSLO3 and SLO1: helices αD and αE in the 
RCK1 domain of one subunit contact the helix αQ in the RCK2 domain of an 
adjacent subunit (see Figure 28b). A notable difference between SLO1 and hSLO3 
occurs in the RCK2 region corresponding to the Ca2+ bowl in SLO1: the 
equivalent residues in hSLO3 form an extended alpha helix (named αQ’), which 
becomes part of the inter-subunit assembly interface (Figure 28b). The structure 
of an isolated subunit from the SLO3 gating ring is shown in Figure 28c. The 
overall domain organization of the hSLO3 CTD subunit is the same as for the 
SLO1 CTD subunit, showing a tandem of RCK domains brought together by a 
large interface, which principally consists of the helix-turn-helix motifs from the 
RCK1 and RCK2 domains.  
 
4.1.3) Comparison with the SLO1 gating ring structures 
 The sequence of the human SLO3 channel shares a high degree of 
homology with the sequence of SLO1 channels. In particular, the sequence of the 
human SLO3 CTD is 42% identical to the sequence of the CTD from either 
human or zebrafish SLO1 channels. How, then, does the structure of the hSLO3 
gating ring compare with either the closed or open structure of the SLO1 gating 
ring?  
 Before we examine the structures of the hSLO3 and closed or open SLO1 
gating rings, let us first compare the structures of isolated subunits from each of 
























Figure 28: Structure of the human SLO3 gating ring. 28a) Cartoon representation of the 
hSLO3 gating ring structure with RCK1 colored in blue and RCK2 in red. The gating is 
viewed from the side (left) and form the top, down the four-fold symmetry axis (right). 
The inter-subunit assembly interface and intra-subunit RCK1-RCK2 flexible interface are 
labeled. 28b) Close-up view of the hSLO3 assembly interface, with secondary structure 
elements labeled. In SLO3 an extended helix, αQ’, is present in the region equivalent to 
the Ca2+ bowl in SLO1. 28c) Cartoon representation of a single subunit from the hSLO3 
gating ring. The RCK1 domain is colored in blue, RCK2 is colored in red and the N-
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these tetrameric rings. The overall sub-domain organization of the hSLO3 CTD 
subunit is the same as in SLO1: both RCK domains are formed by a N-terminal 
lobe with a Rossman fold topology, followed by a helix-turn-helix motif and a C-
terminal lobe (Figure 29a). However, the relative orientation of the sub-domains 
in the hSLO3 subunit is quite different than in the closed or open SLO1 
structures. A comprehensive comparison reveals that, in the hSLO3 isolated 
subunit, the RCK1 N-lobe sub-domain changes its orientation with respect to the 
rest of the structure compared to either the closed or open conformation of the 
SLO1 subunit. This is shown in Figure 29b, where the SLO1 isolated subunits are 
aligned onto an hSLO3 subunit by superimposing the Cα atoms of all residues 
except the RCK1 N-lobe. The regions excluding the RCK1 N-lobe align very well. 
However, the orientation of the hSLO3 RCK1 N-lobe matches neither 
conformation of the SLO1 subunit.  
 If we now compare the structures of the entire gating rings between 
hSLO3 and the two conformations of SLO1, the direct result of the re-orientation 
of the RCK1 N-lobes in the individual hSLO3 subunits is that the hSLO3 ring 
does not align well with either the open or closed SLO1 rings. An objective 
comparison of these structures is achieved by superimposing all Cα atoms of the 
tetrameric gating rings. The total Cα RMSDs (calculated using all Cα from a 
tetrameric ring) of these superpositions are very high (4.7 Å for the hSLO3/open 
SLO1 superposition; 5.9 Å for the hSLO3/closed SLO1 superposition). However, 
an interesting difference can be noticed in the region formed by the RCK1 N-
lobes from all four subunits (which I will from now on refer to as the “RCK1 N-
lobe layer”). In the superposition using all Cα atoms, the RMSD in the RCK1 N-
lobe layer (RMSD calculated using Cα belonging to the RCK1 N-lobes from all 
four subunits) between the hSLO3 and open SLO1 gating rings is 3.9 Å, versus 
6.0 Å when hSLO3 is compared to the closed SLO1 conformation. This is shown 
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Figure 29: Comparison between the structure of individual subunits from the hSLO3 
and SLO1 gating rings. 29a) Sub-domain architecture of the hSLO3 subunit, shown for 
RCK1. The sub-domain organization of RCK2 is identical. Magenta sphere shows the 
position of the N-terminal residue. 29b) Superposition of subunits from hSLO3 (red) and 
the open conformation of the SLO1 gating ring (black). The subunits were superimposed 
using the Cα of all atoms excluding the RCK1 N-lobe region. 29c) Same as 29b) but using 
the closed conformation of the SLO1 gating ring. 
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in Figure 30. In Figure 30, the all-Cα superimposed structures are viewed looking 
from the top of the gating ring, down the four-fold symmetry axis, and the RCK1 
N-lobe layers are shown in ribbon representation (SLO3 colored red, SLO1 
colored black). For the rest of the gating ring, where the structures do not align 
well, only the SLO3 structure is shown, in grey. Qualitatively, the objective all-
Cα superpositions show that the overall structure of the hSLO3 gating is 
significantly different from either conformation of the SLO1 gating ring, but that 
the layer formed by the RCK1 N-lobes from all four hSLO3 subunits seems to 
align relatively well with the equivalent region of the open, but not the closed, 
conformation of SLO1. Another important aspect, independent of any 
superposition, can be seen in Figure 30a. Measured from equivalent N-terminal 
residues (K332 in hSLO3, K343 in SLO1, shown as spheres), the diameter of the 
hSLO3 gating ring (94 Å) matches almost exactly the diameter of the open SLO1 
gating ring (93 Å, versus 81 Å in the closed SLO1 gating ring). 
 To further compare the structure of the RCK1 N-lobe layer between the 
tetrameric hSLO3 and SLO1 gating rings, I performed another structural 
alignment by superimposing the Cα atoms in this region (using all four 
subunits). The results are shown in Figure 31. This analysis reveals that, in the 
hSLO3 tetrameric gating ring, the structure of the RCK1 N-lobe layer matches 
very closely the corresponding region in the open conformation of the SLO1 
gating ring (RMSD, measured using atoms from all four subunits: 2.7 Å), 
whereas the rest of the structures align quite poorly (RMSD, measured using 
atoms from all four subunits: 6.5 Å) (Figures 31a, 31c). When the closed 
conformation of the SLO1 gating is used in the same superposition, no significant 
alignment is observed in any part of the structures (Figures 31b, 31c).  
 The hSLO3 structure was solved by molecular replacement using the 
structure of the monomeric Ca2+-bound hSLO1 CTD (PDB ID 3MT5) as search 
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Figure 30: All-Cα  atoms superposition of the hSLO3 and open/closed SLO1 gating 
rings. 30a) Objective superposition of the hSLO3 and open SLO1 gating rings by 
aligning all Cα from the tetrameric structures. The gating rings are viewed from the top, 
down the four-fold symmetry axis. The RCK1 N-lobe regions from the hSLO3 (in red) or 
the open SLO1 (in black) gating rings are shown as ribbon. The rest of the protein, for 
which the superposition is poor and is not shown, is drawn as a grey cartoon 
corresponding to the hSLO3 gating ring structure. The N-termini are shown as spheres. 
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Figure 31: RCK1 N-lobes superposition of the hSLO3 and open/closed SLO1 gating 
rings. 31a) Superposition of the hSLO3 and open SLO1 gating ring structures by 
aligning the RCK1 N-lobes from all four subunits. The RCK1 N-lobe regions from the 
hSLO3 (in red) or the open SLO1 (in black) gating rings are shown as ribbon. The rest of 
the protein, for which the superposition is poor and is not shown, is drawn as a grey 
cartoon. The N-termini are shown as spheres. 31b) Same as 31a), but using the closed 
SLO1 structure. 31c) Cartoon representation of the hSLO3 gating ring colored according 
to the distance between Cα positions in the same superpositions as in 31a) or 31b). Same 
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model. The conformation of this Ca2+-bound hSLO1 monomer is very similar to 
the conformation of an isolated subunit from the open SLO1 gating ring. Since 
the hSLO3 structure was solved at relatively low resolution (3.4 Å), I wanted to 
ensure that the conformation of the SLO1 search model had no effect on the final 
hSLO3 structure, and especially on the architecture of the RCK1 N-lobe. To test 
this, I used an unbiased molecular replacement strategy in which the SLO1 
subunit used as search model is separated into two independent parts: the RCK1 
N-lobe on the one hand, and the rest of the subunit on the other. In a first round 
of molecular replacement, only the part excluding the RCK1 N-lobe is used as 
search model (searching for two copies, because the asymmetric unit in the 
hSLO3 crystals contains two protomers). This gives a first solution, where the 
position of the non-RCK1 N-lobe atoms are defined. In a second round of 
molecular replacement, this first solution is fixed and only the isolated RCK1 N-
lobe is used as searched model (again, searching for two copies). This gives a 
final solution representing the whole hSLO3 subunit. The hSLO3 gating ring 
structure can then be generated by applying the crystallographic symmetry 
operators. The result of this unbiased molecular replacement strategy shows that 
the final hSLO3 gating ring structure is independent of whether the closed or 
open conformation of a SLO1 subunit is used as search model. In each case, the 
final architecture of the hSLO3 gating ring (in particular in the RCK1 N-lobe 
layer) matches the refined structure that I described in this chapter (data not 
shown). 
 Altogether, the hSLO3 gating ring structure resembles most closely the 
open conformation of the SLO1 gating ring. Most importantly, the architecture of 
the RCK1 N-lobe layer in hSLO3 coincides with the architecture observed in the 
open SLO1 gating ring, and the overall diameters of the hSLO3 and open SLO1 
gating rings are identical. Since in SLO1 channels the orientation of the RCK1 N-
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lobe layer is the main structural determinant of the open vs. closed state of the 
gating ring, it is likely that the hSLO3 structure represents the open conformation 
of the hSLO3 gating ring1. The fact that hSLO3 and SLO1 channels are highly 
homologous in amino acid sequence reinforces this hypothesis. In particular, the 
length of the linkers connecting the CTDs to the transmembrane pore is 
absolutely conserved, so that the identical diameters of the hSLO3 and open 
SLO1 gating rings could drive the opening of the pore in a similar manner.  
It is interesting to stress that, whereas the architecture of the RCK1 N-lobe 
layer is conserved between the hSLO3 structure and the open conformation of 
SLO1, in the rest of the gating ring the hSLO3 and open SLO1 structures do not 
align. In particular, the architecture of the “bottom layer” formed by the RCK2 
domains (shown in grey in Figure 31a) is very different in these two gating rings. 
Again, this is a direct consequence of the different positioning of the RCK1 N-
lobe within the individual subunits of these two structures. To “compensate” for 
this re-positioning, the specific orientation of subunits with respect to one 
another is changed between the hSLO3 and open SLO1 tetramers so as to keep 
the architecture of the RCK1 N-lobe layer, but not of the rest of the gating ring, 
unaltered. This raises the possibility that the specific architecture of the RCK1 N-
lobe layer is constrained between SLO1 and SLO3 channels, which I will develop 
more in the final discussion chapter. 
  
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1	  The hSLO3 crystals were grown in a solution with an initial pH of ~6.8, at which hSLO3 
channels are expected to be mostly closed. However, the actual pH in a protein crystal is hard to 
define and, maybe most importantly, the pH dependence of the isolated hSLO3 gating ring does 
not have to be the same as for the entire channel. The value of pH in which the crystals were 
grown might therefore be somewhat irrelevant to estimate whether the structure represents the 
open or closed conformation of the hSLO3 gating ring based on the pH dependence of hSLO3 
currents.	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 In conclusion, the structure of the hSLO3 gating ring provides the first 
molecular snapshot of the pH-sensing unit from a SLO3 channel. However, a 
mechanistic understanding of how an increase in intracellular pH drives the 
opening of SLO3 channels is still lacking. To address this important question, I 
decided to perform functional mutagenesis on SLO3 channels with the goal of 
identifying the amino acid residue(s) responsible for pH sensing. Unfortunately, 
due to the very low expression of hSLO3 currents in heterologous systems, direct 
mutagenesis analysis of hSLO3 channels proved to be prohibitively challenging. 
As a consequence, I decided to perform mutagenesis in the mouse mSLO3 
homolog, whose pH dependence is very similar to hSLO3. Furthermore, the two 
channels share a significant percentage of sequence identity (67 %).  
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4.2 – MECHANISM OF PH SENSING IN MOUSE SLO3 CHANNELS 
 
 
4.2.1) pH sensing residues in mSLO3 
 To identify the pH sensing residues in mouse SLO3 channels, I modified 
single amino-acids by introducing point mutations in the mSLO3 sequence 
(usually to alanine), and analyzed the pH-dependence of the corresponding 
mutant channels by electrophysiology in Xenopus oocytes. I focused my analysis 
on amino-acids containing protonable side-chains (namely: Asp, Glu, His, Lys 
and Arg). I tested the effect of mutations in different regions of the mSLO3 CTD, 
insisting on protonable residues located at protein interfaces that could be 
important for channel function: the inter-subunit assembly interface (in 
particular, I mutated all protonable residues around a large region 
corresponding to the Ca2+ bowl in SLO1), the RCK1-RCK2 helix-turn-helix hinge, 
and the interface between the RCK1 N-lobe and the rest of the protein structure.  
 Out of > 40 positions tested (see Appendix B), mutations of only two 
residues had a significant effect on the pH dependence of mSLO3: His 417 
located in the RCK1 N-lobe, and Asp 912 located in the RCK2 helix-turn-helix 
motif. The pH dependences of the mSLO3 D912N and H417A mutants are shown 
in Figure 32. All traces are normalized to the maximal current obtained at pH 8.5 
([H+] = 3.2 10-9 M). The pH dependence of mSLO3 D912N is dramatically 
impaired compared to wild-type, whereas the H417A mutation abolishes all pH 
sensitivity in the range studied here (pH 7.2 to 8.5, [H+] 6.3 10-8 M to 3.2 10-9 M).  
 A more detailed analysis of the functional effects of the D912N and H417A 
mutations in mSLO3 is still under way. However, a qualitative observation 
suggests that the mutant D912N or H417A mSLO3 channels are constitutively 
more open than wild-type mSLO3. This can be observed in experiments in which 












Figure 32: D912N and H417A mutants in mSLO3 channels. pH dependences of wild-
type, and mutant D912N and H417 channels are shown as in Figure 27. Each point is the 
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the resting membrane potential of intact Xenopus oocytes expressing the different 
channels is measured. In ND-96 buffer approximating physiological conditions 
(96 mM extracellular [Na+], 2 mM extracellular [K+]), the presence of 
constitutively open K+ channels in the oocyte membrane would drive the resting 
potential to more negative values (the reversal potential for K+ in this system is 
around -100 mV). This is precisely what is observed with the D912N and H417 
mutants. Whereas oocytes expressing wild-type mSLO3 channels have a typical 
resting potential of -40 mV, oocytes expressing either the D912N or H417A 
mutants have typical a resting potential of -70 mV. Importantly, this is not due to 
an increase in expression of the mutant channels compared to wild-type (data 
not shown). Rather, the D912N and H417A mutant channels appear to be 
significantly more open than wild-type mSLO3 under resting conditions. 
 
4.2.2) H417 and D912 in the mSLO3 CTD, and conservation in other SLO3 
channels 
 The functional effects of the D912N and H417A mutations in mSLO3 raise 
the possibility that these residues form the “pH sensor” of mSLO3 channels, in 
other words that the protonation state of either or both D912 and H417 side 
chains is the molecular determinant for pH sensing in mSLO3. Can we evaluate 
this hypothesis by looking at where these residues are located within the mSLO3 
CTD? And are these residues conserved in other SLO3 channels, such that the 
pH sensor they might be the same in other species? 
 D912 is conserved in all SLO3 channels, but also in SLO1 channels. 
However, H417 is surprisingly not conserved in the SLO3 family: in all other 
species for which the SLO3 sequence is known, the residue at position 417 is a 
non-protonable proline (Figure 33a). Does this mean that H417 is unlikely to be 
part of the pH sensor in mouse SLO3 channels? As I will describe next, I believe 
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that H417 is indeed the pH sensing residue in the mouse SLO3 protein (i.e. the 
residue which protonation state directly changes upon pH increase, leading to 
channel opening). Rather, the non-conservation of H417 is most likely the 
consequence of two processes: on the one hand, the inherent structural and 
functional plasticity of the gating ring scaffold, and on the other hand, the 
extremely rapid evolution of proteins specialized in reproduction (such as the 
sperm-specific SLO3), which is well described and believed to be an important 
driving force for speciation, limiting cross-species fertilization (201, 202). I will 
discuss this idea further in the final discussion chapter. 
 Since H417 is not conserved in the human SLO3 channel (where it is a 
proline), it is difficult to directly use the hSLO3 structure to understand the 
functional effects of the H417A mutation in mSLO3. The structure of the SLO1 
CTD, on the other hand, offers important insights. In SLO1, the residue 
corresponding to mSLO3 H417 is a lysine (K428 in hSLO1), conserved across 
SLO1 species. K428 is located in the loop between secondary structure elements 
βD and αD in the RCK1 N-lobe. Interestingly, in the SLO1 CTD structure (in the 
closed as well as open state), K428 is involved in a salt bridge interaction with the 
conserved aspartate corresponding to mSLO3 D912 (D921 in hSLO1). The K428-
D921 salt-bridge makes a direct structural connection between the bottom of the 
RCK1 N-lobe and the RCK2 domain in SLO1 channels. The position of these 
residues is shown in Figure 33b, where I used the structure of the Ca2+-free 
hSLO1 CTD structure and replaced K428 with a histidine. In hSLO3, the presence 
of a proline at position 417 changes dramatically the structure of the βD-αD loop, 
which kinks away from RCK2 (Figure 33c). The specific architecture of this loop 
in hSLO3 is most likely due to the unique structural properties of proline 
residues. It is possible that, in mSLO3, the presence of a histidine induces a loop 
conformation resembling what is seen in SLO1.  








































Figure 33: A model for pH gating in mSLO3 channels. 33a) Sequence comparison of 
SLO3 channels at the position corresponding to H417 in mSLO3. In all other species, this 
residue is a proline. 33b) In SLO1 channels, the residues equivalent to mSLO3 H417 and 
D912 form a salt-bridge interaction. The structure from a single subunit of the Ca2+-free 
hSLO1 gating ring is shown, with K428 (equivalent to mSLO3 H417) replaced by an 
histidine. The putative salt-bridge formed by H417 and D912 in mSLO3 connects the 
RCK1 N-lobe and the RCK2 domain in a single subunit. 33c) Architecture of the βD-αD 
loop in the hSLO3 structure. 33d) Mechanistic model for pH gating in mSLO3 channels. 
As the intracellular pH increases, H417 is deprotonated and the salt-bridge interaction 
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4.2.3) A model for pH sensing in mouse SLO3 channels 
 The structural arrangement shown in Figure 33b offers a natural 
hypothesis for the mechanism of pH sensing in mouse SLO3 channels. A salt-
bridge interaction between D912 an H417 would be ideally located to control the 
position of the RCK1 N-lobe with respect to the rest of the mSLO3 CTD. In SLO1, 
the major conformational change during the closed-to-open transition involves 
precisely the movement of the RCK1 N-lobes with respect to the rest of the 
gating ring. Furthermore, the similar arrangement of the RCK1 N-lobes between 
the hSLO3 and open SLO1 gating ring structure suggests that pH gating in SLO3 
channels could involve a repositioning of the RCK1 N-lobes similar to what is 
observed in SLO1 channels. Therefore, I propose that the salt-bridge interaction 
between D912 and H417 in the CTD subunits form the pH-sensitive element of 
the mSLO3 gating ring. Which of these two residues could then be the actual pH 
sensor? H417 is perfectly suited to be the pH-sensing residue, since the histidine 
side-chain has the unique property of having a pKa falling right into the 
physiological range of pH in cells (203).  
 These observations lead me to propose a model for pH sensing in mSLO3 
channels shown in Figure 33d. At low pH, H417 is protonated and makes a salt-
bridge interaction with D912, stabilizing the “closed” conformation of the SLO3 
gating ring. As pH is increased, H417 is deprotonated, the high-energy salt-
bridge interaction is lost and the RCK1 N-lobe is free to change its angle with 
respect to the rest of the structure, leading to channel opening.  
 This model is based on three aspects revealed by the functional 
mutagenesis studies I presented. First, D912 and H417 are the only amino-acids 
whose mutation affected the pH-dependence of mSLO3 currents in a rather 
extensive mutagenesis screen. Second, the H417A mutation completely abolishes 
pH sensing in mSLO3 whereas D912N has a less dramatic effect, compatible with 
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the idea that the protonation state of H417 is the main determinant of mSLO3 pH 
dependence. Third, the H417A and D912N mutant channels appear to be 
constitutively more open than wild-type mSLO3. This is precisely what would 
happen in the context of the model, since in the absence of charges at positions 
417 or 912, the salt-bridge interaction would be lost and the low-pH, “closed” 
state of the mSLO3 channel would be constitutively destabilized. 
 Additional experiments are needed to verify the model. In particular, a 
crucial prediction would be that mutations replacing H417 by an arginine or a 
lysine (H417R or H417K), which side-chains are expected to be constitutively 
protonated in the range of pH considered here due to their high pKa, would lock 
the corresponding mutant mSLO3 channels in a low-pH-like, “closed” 
conformation since the salt bridge would be constitutively present. Another test 
could involve functional experiments were positions 417 and 912 would cross-
linked in a mutant mSLO3: upon cross-linking, the mutant channels should be 
“closed”. These additional experiments are still ongoing. 
 
4.2.4) An experimental system for functional mutagenesis of hSLO3 channels 
 If H417 is indeed the pH sensing residue in mSLO3, the fact that it is not 
conserved in the sequence of other SLO3 channels (in particular hSLO3) is quite 
surprising, especially considering that the pH dependences of mSLO3 and 
hSLO3 are very similar (recall Figure 27). To understand how mouse and human 
SLO3 channels could share almost identical pH sensitivities using different 
molecular mechanisms, we need to understand the molecular details of pH 
sensing in the human hSLO3 channel. As I described above, the low expression 
of hSLO3 in heterologous systems prevents mutagenesis experiments in practice. 
Such low functional expression could be explained by the fact that a specific 
cofactor or interaction partner, missing in heterologous systems, is required for 
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efficient protein folding and/or trafficking of hSLO3 channels. Very recently, a 
study identified a new protein interacting with mSLO3 channels in mouse sperm 
cells (106). This protein, LRRC52, belongs to the family of leucine-rich-repeat-
containing membrane proteins, which also includes a protein known to interact 
with SLO1 (83). LRRC52 is present in the human genome, and I decided to test 
whether the human hLRRC52 interacts with hSLO3 channels in heterologous 
systems, and whether its presence would facilitate the expression of hSLO3 
currents.  
 Co-expressing hLRRC52 with hSLO3 in Xenopus oocytes, I observed that 
this is indeed the case. hSLO3 currents recorded from oocytes expressing both 
hSLO3 and hLRRC52 are greatly increased compared to oocytes expressing 
hSLO3 alone (Figure 34a). The currents recorded from hSLO3 + hLRRC52 most 
likely originate from hSLO3 activity: these currents are blocked by the internal 
application of Ba2+, a non-specific blocker of K+ channels, and furthermore no 
currents can be observed when hLRRC52 is expressed on its own (data not 
shown).  
 Co-expression with hLRRC52 modifies the functional properties of hSLO3 
channels. First, the kinetics of channel opening is slowed down (see the different 
time scales in Figure 34a). Second, the pH-dependence of hSLO3 + hLRRC52 
currents is shifted to lower pH compared to hSLO3 expressed alone (Figure 34b). 
The fact that LRRC52-co-expression has an activating effect on SLO3 channel at a 
given pH has been described for the mouse mSLO3 homolog. Figure 34c shows 
the results of co-expression of mSLO3 channels with the mouse mLRRC52 
protein: pH activation is shifted to lower pH, but this activation effect is less 
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Figure 34: Co-expression of SLO3 channels with LRRC52. 34a) Representative inside-
out patch currents recorded from Xenopus oocytes expressing either hSLO3 channels 
alone or hSLO3 channels and hLRRC52 proteins. 34b-d) Effect of LRRC52 co-expression 
on the pH dependence of hSLO3 and mSLO3 channels. Each figure illustrates a specific 
combination of SLO3 and LRRC52 homologs: human SLO3 + human LRRC52 in 34b); 
mouse SLO3 + mouse LRRC52 in 34c); human SLO3 + mouse SLO3 LRRC52 in 34d). 
Errors bars, when shown, represent the standard errors from 3-5 independent 
measurements. For the hSLO3/hLRRC52 and hSLO3/mLRRC52 co-expression, the 
results shown are from a single experiment.  
  
34a 
34b 34c 34d 
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pronounced than for the human hSLO3 channels. The precise effects of the 
interaction between hSLO3 channels and LRRC52 require further analysis, which 
is still under way. Nonetheless, the pH-dependence observed with the co-
expression of SLO3 and LRRC52 is likely to reflect the pH sensitivity of the SLO3 
channel itself. For example, the human and mouse homologs of LRRC52 affect 
the pH-dependence of, respectively, hSLO3 and mSLO3 channels in a different 
manner (Figures 34b-d). However, co-expressing hSLO3 with the mouse LRRC52 
resembles the co-expression of hSLO3 with human LRCC52 (Figure 34d), 
suggesting that the identity of the SLO3 channel, and not the LRRC52 protein, 
defines the pH-dependence of the SLO3/LRRC52 complex. 
Overall, hLRRC52 co-expression facilitates expression of pH-sensitive 
hSLO3 channels. I believe I now have a robust system in hand in which I can 
analyze the molecular basis of hSLO3 pH-gating using functional mutagenesis. 
This paves the way for the direct comparison of the mechanism of pH sensing in 
human vs. mouse SLO3 channels. At another level, the results presented here 
describe for the first time that hLRRC52 might be an important physiological 
partner of hSLO3 channels. Testing whether this is indeed the case in human 
sperm cells would be very interesting. 
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 In conclusion, my studies of the structure of the human SLO3 gating ring 
on the one hand, and of the mechanism of pH sensing of mouse SLO3 channels 
on the other hand establish a first step towards understanding the molecular 
basis of pH sensing in SLO3 channels. The fact that the mechanism of pH gating 
seem not be conserved between the human and mouse homologs make a 
definitive interpretation difficult, but I hope that mutagenesis studies on the 
human SLO3 channel itself (using co-expression with LRRC52 proteins) will 
allow us to decipher this difference.  
 Nonetheless, the structural and functional studies appear to agree on one 
point: both suggest that, in SLO3 channels, conformational changes restricted to 
the RCK1 N-lobe regions of the tetrameric gating ring might control pH-gating. 
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 In the preceding chapters I have presented my Ph.D. work, part of a very 
collaborative effort, that describes the crystal structures of the intracellular gating 
modules from three eukaryotic SLO K+ channels: the monomeric structure of the 
Ca2+-bound cytoplasmic domain (CTD) from the human SLO1 channel; the 
tetrameric structure of the Ca2+-bound, open gating ring from the zebrafish SLO1 
channel; and the tetrameric structure of the human SLO3 gating ring. These 
structures, together with the Ca2+-free, closed SLO1 gating ring structure from 
the Jiang laboratory, provide the molecular foundations to understand how 
intracellular signals (Ca2+ binding in SLO1, Na+ binding in SLO2 or pH increase 
in SLO3) control the opening of SLO channels. We now have in hand a precise 
framework in which to interpret the vast array of functional analysis that has 
been performed on these proteins over more than three decades. My own studies 
on the mechanism of pH sensing in the mouse SLO3 channel are an illustrative 
example in this respect. 
 In this final chapter, I will summarize my main results and examine them 
in three different contexts. First, I will compare the similarities and differences 
between the mechanisms of intracellular Ca2+ gating of the SLO1 and the 
bacterial MthK channel. This is an interesting example of how, through 
evolution, two proteins containing very similar domains can achieve the same 
function (i.e., activation by intracellular Ca2+) using different strategies. This 
example also highlights the functional and structural plasticity of the gating ring 
scaffold. Second, I will come back to the comparison of hSLO3 gating ring with 
the open conformation of the SLO1 gating ring and show how this comparison 
could indicate convergent mechanistic principles in SLO1 and SLO3 channels. 
Finally, I will look at how our structural studies suggest an added level of 
complexity in the function of SLO channels in that the intracellular gating rings, 
in addition to regulating the ion-conduction pore directly, may also modulate the 
voltage sensor domains. 
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5.1) Ca2+ sensing in SLO1 and MthK channels 
 The crystal structures of the SLO1 CTDs reveal for the first time the 
precise molecular organization of the intracellular Ca2+-sensing apparatus in 
SLO1 channels. The main conclusions of these studies are threefold. First, 
individual SLO1 CTD subunits are formed by two tandem RCK domains (RCK1 
and RCK2), whose architecture is closely related to the RCK domains found in 
bacterial K+ channels. Second, the CTDs from each subunit of a tetrameric SLO1 
channel assemble in a gating ring structure at the intracellular surface of the 
membrane. In the tetrameric SLO1 gating ring, RCK1 domains from all four 
subunits form a layer at the top, while RCK2 domains form a layer at the bottom. 
The Ca2+ bowl in the SLO1 CTD is located on the side of the RCK2 domain and 
creates four Ca2+ binding sites on the outer perimeter of the tetrameric gating 
ring, at the interface between individual subunits. Third, Ca2+ binding in the 
SLO1 gating ring induces a major conformational change in the upper layer of 
RCK1 domains. This translates into an expansion of the gating ring diameter 
(measured from the CTD N-terminal residues) that we can directly relate to the 
opening of the transmembrane ion-conduction pore.  
 To date, the best-described example of an ion channel in which gating is 
mediated by intracellular ligand binding in RCK domains is the bacterial Ca2+-
activated K+ channel MthK (122). As I presented in the introduction chapter, 
MthK and related RCK-containing prokaryotic channels are believed to be 
evolutionarily related to the eukaryotic SLO channels (24, 152), perhaps 
representative of an ancestral K+ channel from which SLO1 evolved. In this 
context, it is interesting to compare the structures and mechanisms of Ca2+ 
activation between SLO1 and MthK.  
At first glance, the structures of the intracellular gating modules of SLO1 
and MthK are highly similar. The bi-lobed architecture of individual RCK 
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domains is strikingly conserved between the two channels: each RCK domain is 
formed by a N-terminal lobe with a Rossman fold topology, followed by a helix-
turn-helix motif and a C-terminal lobe. In MthK, two separate identical RCK 
domains (created by an alternative Met start site) dimerize through a large 
“flexible interface” around their helix-turn-helix motifs in a similar manner than 
RCK1 and RCK2 domains assemble in the SLO1 CTD. Four MthK RCK dimers 
(equivalent to four CTD protomers in SLO1) assemble in a gating ring structure 
in which the inter-subunit “assembly interfaces” involve the same secondary 
structure elements as in the SLO1 gating ring (122). Finally, the open and closed 
structures of the MthK gating ring (122, 155) reveal that channel opening is 
triggered by an increase in diameter of the gating ring upon Ca2+ binding, like in 
SLO1.   
 However, despite these structural resemblances, the actual mechanisms of 
Ca2+ sensing in SLO1 and MthK channels are strikingly different. First of all, the 
ligand binding site in SLO1 sits in a rather unexpected location based on the 
expected properties of RCK domains. The α/β Rossman fold seen in RCK 
domains is a very common structural motif found in enzymes or ligand binding 
proteins, in which the active site or ligand binding site is located at the C-
terminal end of the central β sheet (24, 204-206). RCK domains found in 
prokaryotic channels or transporters are no exception to this rule, and examples 
include Ca2+ binding in MthK (122) or nucleotide binding in the Trk/Ktr 
transporter family (207, 208). Surprisingly, the Ca2+ binding site in the SLO1 
RCK2 domain (the Ca2+ bowl) is not located at this preferred position but rather 
sits on the side of RCK2. As a consequence, in the tetrameric context of the SLO1 
gating ring, Ca2+ binds at the “assembly interface” between subunits, in marked 
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contrast with MthK where the Ca2+ binding sites are located at the “flexible 
interface” within single RCK dimers (Figure 35).  
 Another important difference between the Ca2+-binding CTDs from SLO1 
and MthK lies in the symmetry (or lack thereof) of their structures. Again, the 
MthK CTD “protomer” is an obligate dimer of identical RCK domains because 
both RCK domains originate from the repeated translation of a single gene (122). 
As a result, the MthK gating ring structure possesses, in addition to the global 
four-fold symmetry axis of the channel, two additional two-fold symmetry axes 
in the plane of the gating ring (colored green in Figure 35): the top and bottom 
RCK layers in the MthK gating ring share the same architecture, and the whole 
intracellular structure can be “flipped” upside-down (around one of the two-fold 
axes)  without consequence. On the other hand, the two RCK domains of a SLO1 
subunit are separately encoded within the same gene (perhaps originally 
through a gene duplication process), which allowed the RCK1 and RCK2 
domains to evolve independently. The end result is that, in the SLO1 gating ring, 
the top RCK1 layer is structurally different than the bottom RCK2 layer. This has 
a direct consequence on the ligand-induced conformational changes observed in 
the closed-to-open transition of the SLO1 and MthK gating rings. As I described 
in Chapter 3, the conformational changes in the SLO1 gating ring are mostly 
restricted to the upper RCK1 layer (Figure 24, see also the interpolative movie at 
http://tinyurl.com/7zx3bwb). In contrast, in the MthK gating ring, the 
conformational changes are the same in the top and bottom layers as imposed by 
the added symmetry, and Ca2+ binding causes an expansion of the ring’s height 
in addition to the dilation effect (155). The conformational changes between the 
closed and open conformations of the MthK gating ring are best appreciated by 
looking at an interpolative movie where the two conformations are morphed 
(available at http://tinyurl.com/cwob2wp). Comparing the Ca2+-induced 
















































Figure 35: Comparison of the SLO1 and MthK gating ring structures. 35a) Cartoon 
representation of the Ca2+ bound SLO1 gating ring. RCK1 and RCK2 domains are 
colored blue and red, respectively. Ca2+ ions are shown as yellow spheres. 35b) Cartoon 
representation of the Ca2+ bound MthK gating ring. RCK domains forming the top and 
bottom layers of the structure are colored blue and red, respectively. Ca2+ ions are shown 
as yellow spheres. In both 35a) and 35b), symmetry axes are shown in green in the right 
panels (square: four-fold axis perpendicular to the plane of the figure, arrows: two-fold 





	   113 
conformational changes between the MthK and SLO1 gating ring structures 
highlights the profound mechanistic differences between these two related 
proteins. Overall, this comparison presents an interesting example of how the 
evolution of molecular structure within a class of proteins can give rise to 
different mechanistic strategies to perform a similar function (i.e., triggering the 
opening of the conduction pore of an ion channel upon Ca2+ binding).  
At this point of the discussion, it is interesting to go back to the model I 
put forward for the mechanism of pH sensing in the mouse mSLO3 channel. In 
this model, which remains to be tested, the “pH sensor” in mSLO3 is located at 
the flexible interface, between the bottom of the RCK1-N lobe and the RCK2 
helix-turn-helix motif within the same mSLO3 subunit. Hence in mouse SLO3 
channels (which are believed to have evolved from a SLO1 ancestor as the result 
of a gene duplication event (209)), the pH sensor is located at a different interface 
than the Ca2+ sensor in SLO1. This example, together with the comparison of 
SLO1 and MthK, highlights the fact that gating ring scaffold capable of very high 
functional and structural plasticity. The numerous interfaces existing in these 
structures offer many opportunities for mechanistic remodeling, even between 
closely related channels. This inherent plasticity might manifest itself most 
dramatically in SLO3 channels. In the context of the rapid evolution of proteins 
specialized in reproduction, it is perhaps not so surprising to observe that 
mechanisms of pH sensing can be substantially remodeled between species 
because the gating ring scaffold allows just that. There are probably multiple 
ways to bias the conformation of a gating ring structure upon pH change, 
especially since pH will affect the protonation state of many side chains in the 
protein. Maybe during the rapid evolution of SLO3 channels, these different 
possible mechanisms were extensively sampled. 
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5.2) Comparing hSLO3 and SLO1 structures: functional implications 
 As I already presented in Chapter 4, comparing the structures of the 
gating ring from the human SLO3 channel with the open or closed structure of 
the SLO1 gating ring reveals interesting differences as well as, perhaps most 
importantly, similitudes between these structures. In the hSLO3 gating ring 
structure, the ring’s diameter matches almost perfectly the diameter of the open 
SLO1 gating ring (94 Å vs. 93 Å, respectively, measured from the Cα position of 
the N-terminal residues of two opposite subunits; the diameter of the closed 
SLO1 gating ring is 81 Å). Moreover, the structure of the RCK1 N-lobes from all 
four subunits in the hSLO3 gating ring matches closely the structure of the same 
region in the open SLO1 gating ring, whereas the bottom RCK2 layers from the 
same two structures do not align. If the hSLO3 gating ring is compared with the 
closed conformation of the SLO1 gating ring, no significant similarity can be 
detected between the two tetrameric structures. This led me to propose that the 
human SLO3 gating ring structure represents the “open” conformation of the 
hSLO3 intracellular pH-gating module.  
 I believe that the significant conservation of molecular architecture in the 
RCK1 N-lobe layer between the gating rings of the hSLO3 and Ca2+-bound SLO1 
channels reveals an interesting structural constraint. In a simple description of 
SLO channel gating by intracellular signals, the gating ring can be viewed as a 
module that simply transduces chemical energy (e.g., binding of Ca2+) into 
mechanical work used to pull open the channel’s transmembrane helices. In this 
context, only the overall diameter of the gating ring (measured at the N-terminal 
positions connecting to the pore), but not the details of the gating ring structure, 
determines channel opening. Considering the significant conservation of amino-
acid sequence between SLO1 and SLO3 channels (in particular, the spring-like 
transmembrane-to-CTD linkers have exactly the same length), it is perhaps not 
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surprising that the gating rings from both channels would reach equivalent 
diameters in the open state. But in the context of the high structural plasticity of 
the gating ring scaffold, and keeping in mind the rapid evolution of SLO3 
channels, it is not hard to imagine that a completely different architecture could 
have evolved in SLO3 channels that would preserve the same overall diameter as 
in SLO1, but not the actual structure of the RCK1 layer of the gating ring. Then, if 
the hSLO3 structure really does represent the open conformation of the hSLO3 
gating ring, what could explain the structural conservation we observe in the 
RCK1 N-lobe layer? I can mostly think of two (non-exclusive) possibilities. The 
first possibility would be that the RCK1 N-lobe layer, being the “active” region of 
the gating ring that rearranges during intracellular activation, is structurally 
constrained in the same way that the geometry of the active site (but not 
necessarily the rest of the structure) is conserved within a class of enzymes. Once 
an efficient molecular solution (in our case, a specific rearrangement of the RCK1 
N-lobe layer) exists to perform a given function (in our case, opening the channel 
pore), the same solution is conserved during evolution. A correlate of this 
hypothesis would be that, in the closed state of the hSLO3 gating ring, the 
architecture of the RCK1 N-lobe layer would match the closed conformation of 
the SLO1 gating ring. The second explanation would be that, in SLO channels, 
the RCK1 N-lobe region interacts with other parts of the protein, and that this 
interaction constrains structurally the position of the RCK1 N-lobes. It is possible, 
as I will discuss in the next section of this chapter, that a significant molecular 
interface exists between the RCK1 N-lobe layer and the transmembrane domain 
of a SLO channel. In this case, the conserved architecture of the SLO1 and SLO3 
transmembrane domains (expected based on sequence homology) would 
constrain the actual position of the RCK1 N-lobes between SLO1 and SLO3 
channels in a similar manner. 
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5.3) A possible interface between eukaryotic gating rings and voltage-sensing 
domains 
 With the structures of the gating ring we now have in hand, it becomes 
possible to estimate what the structure of a full SLO channel might look like. I 
created models of a full SLO1 channel with an open or closed gating ring by 
using the same models used in Figure 26 (page 80) and replacing the ion 
conduction pores by the transmembrane domain of the paddle chimera voltage-
dependent KV channel (141)  by aligning the invariant selectivity filters. The 
result is shown in Figure 36. In both the open and closed conformation, the SLO1 
gating ring appears to fit well against the surface of the transmembrane KV 
domain, with ridges from the gating ring fitting naturally into grooves that exist 
between the voltage sensors and the pore. Interestingly, the part of the SLO1 
gating ring coming in close contact with the transmembrane domain in these 
models is precisely the βA-βC region of the RCK1 N-lobe, i.e. the part whose 
structure changes the most dramatically in the close-to-open transition of the 
SLO1 gating ring (Figure 36, recall also Figure 24 page 76). This raises the 
possibility that interactions with the transmembrane domain might functionally 
regulate the movement of the RCK1 βA-βC regions in the channel, and therefore 
influence intracellular gating. Importantly, previous experiments support the 
idea of a structural connection between the gating ring and the transmembrane 
domains of the SLO1 channel. In particular, functional studies have identified a 
putative Mg2+ binding site bridging two Glu residues located in the βA-βC region 
of the RCK1 N-lobe to amino acids on the voltage sensor (210, 211).  
  





























Figure 36: Models of the SLO1 channel. Cartoon representation of the molecular 
models of the SLO1 channel obtained by docking the transmembrane domain of the KV 
chimera channel (PDB ID 2R9R) onto the models shown in Figure 26 (page 80). Models 
obtained using the open and closed conformation of the SLO1 gating ring are shown on 
the left and right panels, respectively. Voltage-sensor domains (VSD) are colored orange, 
pore domains are colored green and RCK1 and RCK2 domains are colored blue and red, 
respectively. In the side view (bottom panels), all domains at the front and the back are 
removed for clarity.   
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 Overall, this very simple modeling exercise suggests that, in eukaryotic 
SLO channels, the interface between the gating ring and the voltage sensor 
domains could be larger than previously appreciated. A direct physical 
interaction between these two gating modules would allow the two synergistic 
signals required for channel activation (membrane voltage and intracellular cue) 
to modulate each other. Only the structure of an entire SLO channel would 
directly address this hypothesis. Considering the progress we made for the 
recombinant expression and purification of SLO channels in Sf9 cells (presented 
in Chapter 2), I am confident that the long-awaited crystal structure of a SLO 
channel is forthcoming. I have no doubt that such structure would reveal an 
unprecedented level of complexity that would be fascinating to decipher in terms 
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MATERIALS AND METHODS 
 
 
1) SLO constructs expression and purification 
 
Protein expression in Pichia yeast 
Protein constructs (described below in the relevant sections) were sub-cloned in 
the PICZ-c vector (Invitrogen). Pichia pastoris cells (HIS+ strain of SMD1163, 
Invitrogen) were transformed by electroporation (BioRad Micropulser) using 
vector linearized with PmeI as described in the manufacturer’s manual. 
Transformants were selected on YPDS plates (Invitrogen) containing 400-1200 
µg/ml Zeocin (Invitrogen), and used to inoculate small-scale cultures in BMGY 
medium (Invitrogen) grown at 30°C overnight. For large-scale expression, 1-L 
cultures in BMGY medium were inoculated using the small-scale cultures and 
cells were grown at 30°C until OD600 reached ~20. Cells were then pelleted, 
resuspended in BMM medium (Invitrogen) and expressed overnight at 30°C. 
Cells were harvested by centrifugation, flash-frozen in liquid N2 and stored at -
80°C. 
 
Protein expression in Sf9 cells 
Protein constructs were sub-cloned in the pFastBac vector (Invitrogen) and 
baculovirus was generated using the Bac-to-Bac system (Invitrogen) following 
the instructions manual. Sf9 cells were cultured at 27°C in supplemented Grace’s 
insect cell medium (Invitrogen) to a density of ~ 1.0 106/mL before infection with 
baculovirus. Infected cells were cultured for ~60 hours at 27°C, then harvested by 
centrifugation and washed in ice-cold PBS. Cell pellets were flash-frozen in 
liquid N2 and stored at -80°C. 
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Protein expression in HEK cells 
Protein constructs were sub-cloned in the pCGFP-EU vector (175). HEK cells 
were grown in 6-well plates in DMEM medium (Invitrogen) in a 37°C incubator. 
HEK cells reaching ~90% confluence were transfected using lipid-mediated 
transfection (Lipofetamine 2000, Invitrogen). Transfected cells were used 48h 
thereafter. 
 
Protein constructs  
The following genes where used as template for subcloning: human SLO1 
HsloM3 (GI: 507922, a gift from L. Toro); Aplysia californica SLO1 (GI: 39545756, a 
gift from L. Kaczmarek); rat SLO2.2 (GI: 11177892, a gift from L. Kaczmarek); 
mouse SLO3 (GI: 86646081, a gift from L. Salkoff); human SLO3 (GI:157074213), 
chicken SLO2.2 (GI: 20338417) and zebrafish SLO1 (GI: 189526846) genes were 
identified in database searches and were synthetized by Bio Basics, Inc. For 
recombinant expression, constructs of interest were fused to a C-terminal GFP 
followed by a deca-histidine affinity tag (GFP-His10) or a 1D4 tag (GFP-1D4, 
amino-acid sequence for 1D4: TETSQVAPA). A PreScission protease (GE 
Healthcare) cleavage site (LEVLFQG) was introduced before the C-terminal GFP. 
The PreScission recognition sequence and a cloning site (EcoRI) result in a stretch 
of amino acids SNSLEVLFQ attached to the C-terminus of all constructs. CTD 
constructs of human hSLO1, chicken gSLO2.2, zebrafish zSLO1 and human 
hSLO3 were expressed as GFP-His10 fusions in Sf9 cells included the following 
amino acids: for hSLO1, residues 341-1056; for gSLO2.2, residues 347-1201, for 
zSLO1, residues 341–1060 with a loop deletion (839–872); for hSLO3, residues 
330-1041 with a loop deletion (831-852). 
 
	   121 
Fluorescence size-exclusion chromatography  
Small-scale cultures of Pichia, Sf9 or HEK were lysed in a buffer containing (in 
mM): 150 KCl (unless stated otherwise), 50 TRIS pH 8.0; 1 EDTA; 40 DDM; 10 
dithiothreitol (DTT) containing protease inhibitor cocktail IV (EMD Biosciences). 
Size-exclusion chromatography on a Superose-6 column (GE Healthcare) was 
carried out in buffer containing (in mM): 150 KCl, 20 TRIS pH 8.0; 1 EDTA; 1 
DDM; 10 DTT. GFP fluorescence was monitored using a Shimadzu RF-10AXL 
detector.  
 
Cell lysis  
The following lysis methods were used: frozen Pichia cells were lysed in a Retsch, 
Inc. Model MM301 mixer mill (5 x 3.0 min. at 25 cps), keeping the grinding jars in 
liquid N2 between milling cycles. Sf9 cells were disrupted by sonication on ice. 
HEK cells were lysed by resuspension in detergent-containing buffer (typically 
40 mM DDM). The following cocktail of protease inhibitors was used for all 
large-scale purification protocols described here: 3 µg/ml aprotinin, 2 mM 
benzamidine, 5 µg/ml leupeptin, 2 µg/ml pepstatin A, 200 µg/ml 4-(2-
Aminoethyl) benzenesulfonyl fluoride hydrochloride, and 250 µM 
phenylmethane sulphonylfluoride (Sigma-Aldrich). Deoxyribonuclease (DNase) 
1 (Worthington) was also included in all lysis buffers. 
 
Purification of detergent-solubilized SLO1 channels 
Pichia or Sf9 cells expressing human or Aplysia SLO1 GFP-1D4 constructs were 
lysed at 4°C in buffer containing: 150 mM KCl; 50 mM HEPES KOH; 50 mM 
DDM or DM; final pH 8.0, containing DNase and protease inhibitors. Lysate was 
incubated for 3 hours at 4°C to allow membrane protein extraction, then clarified 
by centrifugation (30,000xg, 45’, 4°C). Supernatant was added to 1D4-affinity 
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resin pre-equilibrated in 150 mM KCl, 10 mM HEPES KOH, 4 mM DM, final pH: 
7.4. Suspension was layered with argon gas and incubated overnight at 4°C, 
mixing  by gentle inversion. Resin was collected on a column by gravity, washed 
with 2 column volumes (CV) of buffer (150 mM KCl, 10 mM HEPES KOH, 4 mM 
DM, final pH: 7.4, flow rate 0.2 mL/min), and eluted in buffer supplemented 
with 1 mg/ml 1D4 peptide (AnaSpec, Inc.) over 1 hour at room temperature. 10 
mM DTT and PreScission protease (1:40 w/w) were added to the eluted protein. 
Protease cleavage was carried out for 4 hours at 4°C, after which the protein was 
concentrated and further purified by gel filtration at 4°C on a Superose-6 column 
in buffer containing: 150 mM KCl; 20 mM HEPES KOH; 6 mM DM 10 mM DTT; 
final pH: 7.4. The fraction corresponding to the tetramer peak was isolated and 
concentrated to ~1-5 mg/mL. 
 
Purification of CTD constructs 
CTD constructs of human hSLO1, chicken gSLO2.2, zebrafish zSLO1 and human 
hSLO3 were expressed as GFP-His10 fusions in Sf9 cells. The following buffers 
were used during cell lysis at 4°C. For hSLO1, gSLO2.2 and zSLO1 (in mM): 300 
NaCl, 50 HEPES pH 8.0, 10 imidazole, and 5 β-mercaptoethanol (β−ΜΕ), 
containing DNase and protease inhibitors. For hSLO3 (in mM): 500 KCl; 50 K-
phosphate; 10 imidazole and 5 β−ΜΕ, final pH 8.0,  containing DNase and 
protease inhibitors. The cell lysate was clarified by ultracentrifugation 
(250,000xg, 80’, 4°C). Supernatant was applied by gravity onto TALON metal 
affinity resin (Clontech) pre-equilibrated in lysis buffer, at 4°C. The resin was 
then washed with 10 column volumes of lysis buffer supplemented with extra 10 
mM imidazole and eluted in lysis buffer supplemented with extra 290 mM 
imidazole (all steps at 4°C). 10 mM DTT and PreScission protease (1:40 w/w) 
were added to the eluted protein. Protease cleavage was carried out overnight at 
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4°C, after which the protein was concentrated and further purified by gel 
filtration at 4°C on a Superose-6 column. The following gel filtration buffers were 
used. For hSLO1 (in mM): 150 NaCl, 20 TRIS pH 8.0, 50 CaCl2, 20 DTT, and 1.5 
TRIS(2-carboxyethyl)phosphine (TCEP). For gSLO2.2 (in mM): 500 NaCl, 20 TRIS 
pH 8.0, 20 DTT, and 1.5 TCEP. For zSLO1 (in mM): 150 NaCl, 20 HEPES pH 8.0, 
20 DTT. For hSLO3 (in mM): 500 KCl, 20 K-phosphate, 20 DTT, 1.5 TCEP, final 
pH 8.5. For crystallization experiments, all proteins were concentrated to 5-6 
mg/mL. For the zSLO1 CTD, 10 mM CaCl2 was added to the protein before 
crystallization. 
 
2) IbTx binding studies 
 
Recombinant IbTx expression and purification 
Recombinant iberiotoxin (IbTx) expression in E. coli was based on protocols 
originally described for charybdotoxin (188, 212), with minor modifications. IbTx 
was expressed in E. coli BL21(DE3) cells as a fusion construct containing the T7 
gene 9 sequence and a factor Xa cleavage site before the toxin N-terminus. Large-
scale bacterial cultures were grown in standard LB medium at 37°C and protein 
expression was induced when OD600 reached 0.9 using 0.5 mM IPTG. Induction 
was carried out for 2.5 hours, after which the cells were pelleted and flash-frozen 
in liquid N2. Cells were resuspended in ice-cold lysis buffer (in mM): 50 NaCl, 10 
TRIS pH 8.0, 2 EDTA, 7 β−ME, containing DNase and protease inhibitors. 
Mechanical lysis was performed using a French press. The lysate was clarified by 
centrifugation (30,000xg, 45’, 4°C), after which DNA was precipitated using 30% 
w/v streptomycin sulfate, stirring for 10’ on ice. The solution was spun down 
(30,000xg, 20’, 4°C), and solid ammonium sulfate was slowly added to the 
supernatant (31 g ammonium sulfate per 100 mL of supernatant, i.e. 50% 
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saturation). Ammonium sulfate precipitation was carried on overnight at 4°C 
under gentle stirring. The precipitate was collected by centrifugation (30,000xg, 
20’, 4°C) and the pellet dissolved in 50 mM NaCl, 50 mM TRIS pH 7.0, 5 mM β-
ME. The T7 gene 9-IbTx fusion was then purified by ion-exchange 
chromatography on a DE-52 column at 4°C (salt gradient: 50 to 500 mM NaCl in 
50 mM TRIS pH 7.0, 5 mM β-ME). Fractions containing the fusion protein were 
dialyzed against 100 mM NaCl, 20 mM HEPES pH 8.0, 1 mM β-ME for 3 days at 
4°C. After diluting the dialyzed protein solution to A280 = 2.0 (in dialysis buffer), 
1 mM CaCl2 was added and the fusion protein was cleaved using 10 µg/mL 
trypsin (45’ at room temperature (RT), stirring). IbTx was isolated using ion-
exchange chromatography on a mono-S column (salt gradient: 10-1000 mM NaCl 
in 10 mM HEPES, pH 8.0). The main fraction (pure IbTx) was isolated and 
supplemented with 5% v/v acetic acid, then incubated for 4 hours at 65°C for 
cyclization of the N-terminal glutamine. IbTx was then further purified by HPLC 
on a C18 column, using a 10-45 % gradient (buffer A: 0.1 % trifluoroacetic acid 
(TFA) in H2O; buffer B: 0.1 % TFA in 9:1 acetonitrile:H2O). The purified IbTx was 
collected and lyophilized, and its mass confirmed by mass spectrometry.  
For the purification of the IbTx-D19C mutant, the same protocol was followed 
except that a glutathione adduct was formed after trypsin cleavage by the 
sequential addition of 0.5 mM DTT (30’ at RT, stirring) and oxidized glutathione 
(1h at RT, stirring).  
 
IbTx resin generation 
The gluthatione-protected IbTx-D19C mutant was reacted with 10 mM DTT in 50 
mM Na-phosphate pH 7.0 (30’ at RT), and the reduced toxin was purified by 
HPLC as described above. The IbTx-D19C fraction was lyophilized in a vacuum 
concentrator and dissolved in coupling buffer (50 mM TRIS pH 8.2, 5 mM Na-
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EDTA), then incubated at RT for 30 minutes. The toxin was then coupled to 
SulfoLink resin (Pierce) using the free sulfhydryl group of the introduced Cys19 
(5 hours at RT with gentle stirring). Any unreacted iodoacetamide groups on the 
resin were then capped by treatment of the resin with 1% β-ME in coupling 
buffer for 1 h at RT. Following the capping reaction, the resin was extensively 
washed in coupling buffer, and stored at 4°C as 50 % slurry in 50 mM NaCl, 10 
mM Na-phosphate pH 7.0, 0.05 % Na-azide. A control resin “mock” resin was 




The IbTx-D19C mutant was labeled using maleimide derivatives by reaction onto 
the sulfhydryl group of the introduced Cys19 using protocols previously 
described for ChTx (188). Briefly, IbTx-D19C was deprotected and HPLC 
purified as described above. The deprotected toxin was then reacted using slight 
excess (1.1 x) of NEM derivatives in 50 mM NaCl, 50 mM Na-phosphate pH 7.0. 
The reaction was carried out for 15 minutes at room temperature, after which the 
labeled IbTx was purified by HPLC as described above. Two maleimide 
derivatives were used: the fluorescent tetramethylrhodamine-5-maleimide 
(Molecular Probes) and the radioactive 14C-N-ethylmaleimide (Perkin Elmer). For 
the reaction with 14C-N-ethylmaleimide, two diastereomers were obtained and 
both forms were used. Masses of the labeled compounds were confirmed by 
mass spectrometry. To measure the specific activity of 14C-IbTx, toxin 
concentration was determined using absorbance at 280 nm and the theortical 
extinction coefficient predicted on the basis of the amino-acid sequence: ε = 7400 
M-1 cm-1. The measured specific activity was 31.5 ±0.3 Ci/mol. 
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IbTx pull-down assays and 14C-IbTx binding assays 
To avoid the use of reducing agents during the IbTx binding assays on 
solubilized SLO1 channels, 5 mM iodoacetamide was added at the beginning of 
cell lysis during SLO1 purification to cap endogenous cysteines. Then, reducing 
agents were omitted during all the steps of channel purification described above.  
Pull-down assays were typically performed in assay buffer containing 150 KCl 
(unless stated otherwise), 50 HEPES pH 8.0 and 3 mM DM. 150 µL of solution 
containing solubilized SLO1 channel was incubated with 20 µL of IbTx-resin (40 
µL of 50 % slurry) and binding was carried out at room temperature for 90 
minutes under gentle mixing. The beads were then washed extensively in ice-
cold assay buffer (using sequential centrifugation steps). Resin-bound channels 
were eluted by boiling the resin in 1x SDS-sample buffer before SDS-PAGE 
analysis.    
14C-IbTx binding assays were performed following previously described 
protocols (182, 183), with a few modifications. SLO1 channels were purified in 
binding buffer containing 150 mM KCl, 20 mM HEPES pH 7.4, 50 mM CaCl2 and 
6 mM DM. Binding reaction were set up in a total volume of 100 µL by mixing 
100 nM receptor (i.e., tetrameric channel) with 10-1000 nM 14C-IbTx and 
incubating the reaction for 1 hour at RT with gentle shaking. Channel-toxin 
complexes were recovered on G4 glass filters (Whatman) pre-incubated in 0.5 % 
polyethyleneimine (in H2O). The filters were washed extensively in ice-cold 
buffer (150 mM KCl, 20 mM HEPES pH 7.4) using a vacuum filtering system. The 
washed filters were finally counted for 14C radiation by scintillation. Non-specific 
binding was determined from control samples containing a large excess (> 60 x) 
of unlabeled IbTx.  
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3) Crystallization and structure determination 
 
Monomeric Ca2+-bound hSLO1 CTD structure and gSLO2.2 crystals 
The hSLO1 CTD was crystallized at 20°C by hanging-drop vapor diffusion 
against reservoir solution containing 50 mM TRIS, 9-12% (v:v) PEG 400, and 100 
mM potassium phosphate (pH 8.0). Tetragonal crystals belonging to space group 
I422 grew to full size within a week and were cryoprotected by increasing the 
concentration of PEG 400 to 30% in the reservoir solution supplemented with 500 
mM NaCl. Diffraction data for native crystals of human SLO1 CTD were 
measured at the Advanced Photon Source beamline 24 ID-C. Diffraction data for 
selenomethionine-substituted crystals of the hSLO1 CTD and the gSLO2.2 CTD 
crystals were collected at beamline X29 from the National Synchrotron Light 
Source. All diffraction images were processed with the HKL2000 program suite 
(213). Initial MAD phasing for hSLO1 CTD was calculated using 
SOLVE/RESOLVE (214). Thirteen selenium sites were found and the solvent-
flattened electron density map at 3.3 Å resolution was of high quality. The 
protein chain was readily traceable and iterative model building was carried out 
in COOT (215). Rounds of refinement were performed with REFMAC. The final 
model was refined to 3.0 Å resolution with Rwork = 0.246 and Rfree = 0.278. A few 
disordered loop regions were not built due to poor electron density and the final 
refined model includes residues 343-570, 577-613, 677-806, 817-833, 869-945, 949-
1020, and 1025-1056. All side chains but two (L353 and W477) were modeled. The 
majority (94.6%) of the residues lie in the most favored region in a 
Ramachandran plot (216), with the remaining 5.4% in the additionally allowed 
regions. One Ca2+ ion and one SO42- were modeled in the structure. For molecular 
replacement, a poly-alanine model for the refined SLO1 CTD structure was used 
as the search model against the 6.0 Å diffraction data from the gSLO2.2 CTD. A 
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unique solution with a standout Z-score was identified using the program 
PHASER (1). Data collection and structure refinement statistics are shown in 
Table 1. All structural illustrations and electron density maps were prepared 
with PYMOL (www.pymol.org). 
 
Open structure of the zSLO1 gating ring 
Crystals of the zebrafish SLO1 CTD were grown at 20°C using hanging-drop 
vapor diffusion by mixing equal volumes of protein and a reservoir solution 
containing 50 mM 2-(N-morpholino)ethanesulfonic acid (MES), 4% (w/v) PEG 
4000 and 100 mM potassium sodium tartrate (pH 6.3). The crystals grew to a 
maximum size of about 0.2 mm x 0.2 mm x 0.3 mm within three days. Before 
being flash frozen in liquid nitrogen, the crystals were briefly transferred to a 
cryoprotectant solution containing 50 mM MES, 6% (w/v) PEG 4000, 100mM 
potassium sodium tartrate, 150mM NaCl, 10 mM CaCl2 and 30% ethylene glycol 
(pH 6.3). The crystals belong to space group P212121 and the unit cell has 
dimensions of a = 137.65 Å, b  = 210.82 Å and c = 238.76 Å with α = β = γ = 90°. 
Each asymmetric unit contains eight protein subunits. 
Diffraction data were measured at beamline X29 of the National Synchrotron 
Light Source and were processed with the HKL2000 program suite (1). The 
scaled data set was anisotropically corrected to resolution limits of 4.0, 3.6 and 
3.6 Å along the reciprocal cell directions a*, b*, and c*, respectively, using the 
diffraction anisotropy server at the University of California, Los Angeles (200). 
An isotropic B factor of 229.98 Å2 was applied to restore the magnitude of the 
high-resolution reflections diminished by anisotropic scaling. The structure was 
determined by molecular replacement using the monomeric Ca2+-bound human 
SLO1 CTD (PDB ID 3MT5) as the search model. Initial phases were improved by 
eight-fold non-crystallographic symmetry averaging carried out with DM from 
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the CCP4 program suite (217). Iterative model building was carried out in COOT 
(1). Rounds of refinement were performed with CNS (218) and REFMAC (219), 
and strong eight-fold non-crystallographic symmetry restraints were maintained 
throughout refinement. The final model was refined to a resolution of 3.6 Å with 
Rwork = 0.260 and Rfree = 0.289. A few disordered regions were not modeled owing 
to weak electron density, and the final refined model includes residues 343–571, 
581–614, 688–810, 817–837, 875–949, 953–1,024 and 1,029–1,059. Residues for 
which side-chain density was poorly defined were modeled as alanines. The 
majority (95.9%) of the residues lie in the most favored region in a 
Ramachandran plot, with the remaining 4.1% in the additionally allowed 
regions. Eight Ca2+ ions were modeled in the Ca2+ bowls from the two gating 
rings in the crystal. Data collection and structure refinement statistics are shown 
in Table 2. All structural illustrations were prepared with PYMOL 
(www.pymol.org). The multiple-chain morphing script for CNS (220) was used 
to generate coordinates for the movies described in Chapter 3. 
 
hSLO3 gating ring structure 
Crystals of the human SLO3 CTD were grown at 20°C using hanging-drop vapor 
diffusion by mixing equal volumes of protein and a reservoir solution containing 
50 mM K-phosphate, 3% (w/v) PEG12000 and 1 M ammonium formate (final 
pH: 6.3). The pH of the final solution obtained by mixing equal amounts of 
protein and reservoir solutions was measured to be 6.8. The crystals grew to a 
maximum size of about 0.4 mm x 0.15 mm x 0.05 mm within three days. Crystals 
were sequentially transferred into cryoprotective solutions (all containing 500 
mM KCl, 70 mM K-phosphate, 4% (w/v) PEG12000, 1 M ammonium formate, 
final pH 6.4) containing increasing concentrations of ethylene glycol (5%, 10%, 
20%, final ethylene glycol concentration of 30 % (w/v)) before being flash-frozen 
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in liquid N2. The crystals belong to space group I222 and the unit cell has 
dimensions of a = 124.54 Å, b = 157.94 Å and c = 249.01 Å with α = β = γ = 90°. 
Each asymmetric unit contains two CTD subunits. 
Diffraction data were measured at beamline X29 of the National Synchrotron 
Light Source and were processed with the HKL2000 program suite (213). 
Diffraction of X-rays by these crystals was very anisotropic, and analysis 
revealed that diffraction in the a* and b* directions of the reciprocal cell are the 
weakest. In the final dataset used for structure determination, diffraction data 
collected from two independent crystals that varied in their degree of diffraction 
anisotropy were merged. These reflections were scaled together in SCALEPACK 
(213) to produce a unique, final dataset. The scaled data set was anisotropically 
corrected to resolution limits of 3.8, 3.4 and 3.3 Å along the reciprocal cell 
directions a*, b*, and c*, respectively, using the diffraction anisotropy server at 
the University of California, Los Angeles (200). An isotropic B factor of 105.89 Å2 
was applied to restore the magnitude of the high-resolution reflections 
diminished by anisotropic scaling. The structure was determined by molecular 
replacement using the monomeric Ca2+-bound human SLO1 CTD (PDB ID 3MT5) 
as the search model. Structure refinement was carried out in REFMAC (219) 
using strong two-fold non-crystallographic symmetry restraints. Iterative model 
building was carried out in COOT (215). The final model was refined to a 
resolution of 3.4 Å with Rwork = 0.248 and Rfree = 0.268. A few disordered regions 
were not modeled owing to weak electron density, and the final refined model 
includes residues 332–353, 362–371, 378–559, 567–601, 681–702, 706–806, 812-829, 
858-932, 952-970, 981-1007, 1014-1040 and 1,029–1,059. Residues for which side-
chain density was poorly defined were modeled as alanines. The majority 
(93.0%) of the residues lie in the most favored region in a Ramachandran plot, 
with the remaining 7% in the additionally allowed regions. Data collection and 
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structure refinement statistics are shown in Table 3. All structural illustrations 




Purified SLO1 channel reconstitution 
Channel reconstitution was done following the procedure described in (221). 
Lipids (1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine:	   1-Palmitoyl-2-
oleoyl-sn-glycero-3-phosphoglycerol, i.e. POPE:POPG, 3:1 w/w) in chloroform 
were transferred with a glass syringe into a glass test tube, dried with an argon 
stream, washed with pentane, and then placed under room vacuum for 30 
minutes. Dried lipids were then hydrated with dialysis buffer containing 450 
mM KCl and 10 mM HEPES-KOH pH 7.4 at a lipid concentration of 10 mg/ml. 
The lipid suspension was vortexed briefly and sonicated 5-10 times (30 second 
each) to produce small unilamellar vesicles. DM was added into the vesicle 
suspension to a final concentration of 10 mM. The mixture was rotated for 30 
minutes at room temperature and then solubilized SLO1 protein was added to 
the lipid/detergent mixture to a protein-to-lipid ratio (w/w) ranging from 0.1 to 
1.0. Detergent concentration was then raised to 17.5 mM. The mixture was 
incubated for two hours at room temperature and then dialyzed against the 
dialysis buffer at 4°C. The buffer was changed every 12 hours. After three days 




The bilayer experiments followed published procedures (221, 222). Lipids 
(POPE:POPG 3:1 w/w) were dried under argon and dissolved in decane, then 
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were painted over a 300 µm hole in a polystyrene partition that separated two 
aqueous chambers. Once formation and thinning of a planar lipid membrane was 
detected through monitoring of the electrical capacitance, lipid vesicles were 
delivered to the membrane surface with a pipette. Vesicle fusion was facilitated 
by the presence of a salt gradient across the membrane: 15 mM KCl on the side 
opposite vesicle addition (trans side) and 150 mM KCl on the side of vesicle 
addition (cis side). Both sides were buffered with 10 mM HEPES-KOH at pH 7.4. 




Full length hSLO3 channel was cloned into the pGEM-HE vector (223). The 
constructs of mSLO3 in pOX (94) and of human and mouse LRRC52 in pXMX 
were generous gifts from L. Salkoff and C. Lingle, respectively. Plasmids were 
linearized and capped cRNA was produced by in vitro transcription using the 
mMessage mMachine reagents (Invitrogen). cRNA was purified using 
phenol/chloroform extraction and ethanol purification, and stored at -80°C. 
Oocytes were dissected from anesthetized Xenopus leavis (African clawed frogs) 
by a survival surgery. Oocytes were immediately treated with collagenase (2 
mg/mL) for 1.5 hours, rinsed with a Ca2+-free OR-2 solution (82.5 mM NaCl, 2.5 
mM KCl, 1 mM MgCl2, 5 mM HEPES pH 7.6) and stored in ND-96 solution (96 
mM NaCl, 2 mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 5 mM HEPES pH 7.6) 
containing fresh gentamycin (50 mg/L). Within 2 days of dissection, oocytes 
were injected with ~10 ng of purified RNA. For SLO3/LRRC52 co-expression 
studies, the two constructs were injected in a 1:1 w/w ratio. Electrophysiological 
measurements were made 3-6 days after injection. Oocytes were incubated at 
18°C.  
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For recording, inside-out patches were excised from freshly devitellinized 
oocytes using fire-polished glass pipettes with a typical resistance of 0.8-1.2 MΩ. 
Large pipettes were used in order to increase the amplitude of SLO3 current in a 
patch. Axopatch amplifier 200B (Axon Instruments), a digitizer (Axon 
Instruments DigiData 1440A) and Clampex 10.2 software (Axon Instruments) 
were used in the recording of data. Patches were excised in an inside-out 
configuration, exposing the intracellular face of membrane and embedded 
channels to a bath solution controlled by a custom-built gravity-flow perfusion 
system. Pipette solution contained (in mM): 140 K-gluconate, 20 HEPES, 2 MgCl2, 
with pH adjusted to 7.0. Bath solutions contained (in mM): 140 K-gluconate, 20 
HEPES, 5 EGTA (acid form), and pH was carefully adjusted with KOH to the 
desired value. During recording, the membrane voltage was held at -60 mV and 
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!
Datasets Native Selenium gslo2.2 CTD 
Resolution (Å) 3.0 3.3 6.0 
Space Group P6322 P6322 I422 
Source APS 24ID-C BNL X29 BNL X29 
Cell Constants  
a, b, c (Å) 
a, b, g( (°)) 
a = b = 144.5 
c = 182.2 
90, 90, 120 
a = b = 145.1  
c = 182.4 
90, 90, 120 
  
a = b = 126.3   
c = 239.0 
90, 90, 90 
  Peak Inflection Remote  
Wavelength (Å) 0.9792 0.9792 0.9793 0.9640 1.0750 
Completeness (%) 99.9 (99.9) 99.8 (100) 99.8 (100) 99.8 (100) 95.3 (96.7) 
Rmerge 0.089 (0.738) 0.105 (0.493) 0.100 (0.533) 0.130 (0.745) 0.108 (0.746) 
Reflections 23149 17611 17641 17649 2520 
I/! 19.6 (2.4) 18.8 (3.3) 18.2 (3.1) 13.9 (2.2) 21.4 (3.1) 
Redundancy 5.8 (5.9) 7.0 (7.2) 7.0 (7.2) 7.0 (7.2) 9.1 (9.6) 
MAD Phasing (SOLVE/RESOLVE) 
Number of sites 13 
Resolution (Å) 3.3 
Overall Figure of Merit 0.70 
Refinement 
Resolution (Å) 50 - 3.0 
Rwork 0.249 (0.327) 
Rfree 0.282 (0.324) 
Number of atoms 
Protein 4692 
Ligand (Ca2+) 1 
Average B factors (Å2) 67.1 
Ramachandron plot 
Favored (%) 94.3 
Allowed (%) 5.7 
Disallowed (%) 0 
RMSD Bond lengths(Å) 0.010 
RMSD Bond angles (°) 1.214 
Rfree was calculated with 5% of the data. 
Numbers in parentheses represent values in the highest-resolution shell. 
TABLES 
 
Table 1:  Summary of crystallography data for the monomeric Ca2+-bound 
hSLO1 CTD structure presented in Chapter 3 
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Table 2:  Summary of crystallography data for the Ca2+-bound zSLO1 gating 





























































 Zebrafish SLO1 CTD 
Data collection 
Resolution (Å) 3.6 
Space group P212121 
Source BNL X29 
Cell dimensions:  a, b, c (Å) 
                      !, ", #( (°)) 
137.65, 210.82, 238.76 
90, 90, 90 
Wavelength (Å) 1.075 
Completeness (%) 99.4 (99.5) 
Rmerge 0.103 (0.794) 
I/$I 11.9 (1.5) 





High (a*, b*, c*)a 
 
48 
4.0, 3.6, 3.6 
No. of reflections (total / test) 71878 / 3620 
Completeness (%)b 93.8 (30.9) 
Rwork 0.283 (0.386) 
Rfree 0.293 (0.391) 
Number of atoms 
Protein 37304 
Ligands (Ca2+) 8 
Average B factors (Å2) 99.3 
Ramachandron plot 
Favored (%) 95.9 
Allowed (%) 4.1 
Disallowed (%) 0 
RMSD Bond lengths (Å) 0.007 
RMSD Bond angles (°) 1.138 
Rfree was calculated with ~5% of the data.   
Numbers in parentheses represent values in the highest-resolution shell. 
a Reflections beyond these limits were excluded from refinement after 
anisotropic correction (a*, b*, and c* indicate reciprocal cell directions).  
b Completeness after anisotropic correction. 
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Table 3:  Summary of crystallography data for the hSLO3 gating ring structure 















































Datasets Dataset #1 Dataset #2 Merged dataset 
Resolution (Å) 3.3 3.4 3.3 
Space Group I222 I222 I222 
Source BNL X29 BNL X29  
Cell Constants  
a, b, c (Å) 
 
!, ", #( (°)) 
a = 124.10 
b= 158.90 
c =  248.27 
90, 90, 90 
a = 124.53 
b= 157.94 
c =  249.00 
90, 90, 90 
  
a = 124.54 
b = 157.94  
c = 249.00 
90, 90, 90 
Wavelength (Å) 1.075 1.29    
Completeness (%) 99.6 (100) 99.7 (100)   99.9 (100) 
Rmerge 0.081 (0.810) 0.095 (0.957)   0.124 (>1) 
Reflections 23149 17611   2520 
I/$ 15.9 (1.6) 12.5 (1.3)   15.0 (1.8) 
Redundancy 4.8 (4.8) 3.5 (3.4)   8.3 (8.3) 
Refinement (using anisotropic correction) 
Resolution (Å) 
Completenessb  
50 - 3.4 (a*, b*, c*: 3.8, 3.4, 3.4)a 
90.0 (38.6) 
Rwork 0.248 (0.324) 
Rfree 0.266 (0.286) 
Number of atoms 
Protein 8154 
Average B factors (Å2) 69.6 
Ramachandron plot 
Favored (%) 93 
Allowed (%) 7 
Disallowed (%) 0 
RMSD Bond lengths(Å) 0.008 
RMSD Bond angles (°) 1.002 
Rfree was calculated with 5% of the data. 
Numbers in parentheses represent values in the highest-resolution shell. 
a Reflections beyond these limits were excluded from refinement after anisotropic correction (a*, 
b*, and c* indicate reciprocal cell directions). 
b Completeness after anisotropic correction 
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APPENDIX 
 





Sequence alignment of SLO family RCK domains. Human sequences representing the 
three main families of SLO channels (hSLO1, hSLO2.2 and hSLO3) are aligned together 
with a chicken SLO2 family member (gSLO2.2) and MthK. The alignment of hSLO1 and 
MthK is based on their known RCK domain structures. The MthK sequence is repeated 
to align to the second RCK domain present in SLO family sequences. In regions with low 
sequence identity and significant insertions and deletions, manual alignment was aided 
by the SLO1 structure. Two levels of shading indicate sequence identity across all SLO 
family members (dark blue) versus identity across only 3 of 4 representative members 
(light blue). The same shading is extended to the MthK sequence when identical to the 
Slo family sets. The definition of sequence identity was relaxed to include D/E and K/R 
substitutions. 
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